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 I 
Summary 
 
 
The cardiovascular regulation undergoes wide changes in the different states of sleep-
wake cycle. In particular, the relationship between spontaneous fluctuations in heart 
period and arterial pressure clearly shows differences between the two sleep states. In 
non rapid-eye-movement sleep, heart rhythm is under prevalent baroreflex control, 
whereas in rapid-eye-movement sleep central autonomic commands prevail (Zoccoli et 
al., 2001). Moreover, during rapid-eye-movement sleep the cardiovascular variables 
show wide fluctuations around their mean value. In particular, during rapid-eye-
movement sleep, the arterial pressure shows phasic hypertensive events which are 
superimposed upon the tonic level of arterial pressure. These phasic increases in arterial 
pressure are accompanied by an increase in heart rate (Sei & Morita, 1996; Silvani et 
al., 2005). Thus, rapid-eye-movement sleep may represent an “autonomic stress test” 
for the cardiovascular system, able to unmask pathological patterns of cardiovascular 
regulation (Verrier et al. 2005), but this hypothesis has never been tested 
experimentally. 
The aim of this study was to investigate whether rapid-eye-movement sleep may 
reveal derangements in central autonomic cardiovascular control in an experimental 
model of essential hypertension. The study was performed in Spontaneously 
Hypertensive Rats, which represent the most widely used model of essential 
hypertension, and allow full control of genetic and environmental confounding factors.  
In particular, we analyzed the cardiovascular, electroencephalogram, and 
electromyogram changes associated with phasic hypertensive events during rapid-eye-
movement sleep in Spontaneously Hypertensive Rats and in their genetic Wistar Kyoto 
control strain. Moreover, we studied also a group of Spontaneously Hypertensive Rats 
made phenotypically normotensive by means of a chronic treatment with an angiotensin 
converting enzyme inhibitor, the Enalapril maleate, from the age of four weeks to the 
end of the experiment. All rats were implanted with electrodes for 
electroencephalographic and electromyographic recordings and with an arterial catheter 
for arterial pressure measurement. After six days for postoperative recovery, the rats 
were studied for five days, at an age of ten weeks. 
 II
The study indicated that the peak of mean arterial pressure increase during the phasic 
hypertensive events in rapid-eye-movement sleep did not differ significantly between 
Spontaneously Hypertensive Rats and Wistar Kyoto rats, while on the other hand 
Spontaneously Hypertensive Rats showed a reduced increase in the frequency of theta 
rhythm and a reduced tachicardia with respect to Wistar Kyoto rats. The same pattern of 
changes in mean arterial pressure, heart period, and theta frequency was observed 
between Spontaneously Hypertensive Rats and Spontaneously Hypertensive Rats 
treated with Enalapril maleate. Spontaneously Hypertensive Rats do not differ from 
Wistar Kyoto rats only in terms of arterial hypertension, but also due to multiple 
unknown genetic differences. Spontaneously Hypertensive Rats were developed by 
selective breeding of Wistar Kyoto rats based only on the level of arterial pressure. 
However, in this process, multiple genes possibly unrelated to hypertension may have 
been selected together with the genetic determinants of hypertension (Carley et al., 
2000). This study indicated that Spontaneously Hypertensive Rats differ from Wistar 
Kyoto rats, but not from Spontaneously Hypertensive Rats treated with Enalapril 
maleate, in terms of arterial pH and theta frequency. This feature may be due to genetic 
determinants unrelated to hypertension. In sharp contrast, the persistence of differences 
in the peak of heart period decrease and the peak of theta frequency increase during 
phasic hypertensive events between Spontaneously Hypertensive Rats and 
Spontaneously Hypertensive Rats treated with Enalapril maleate demonstrates that the 
observed reduction in central autonomic control of the cardiovascular system in 
Spontaneously Hypertensive Rats is not an irreversible consequence of inherited genetic 
determinants. Rather, the comparison between Spontaneously Hypertensive Rats and 
Spontaneously Hypertensive Rats treated with Enalapril maleate indicates that the 
observed differences in central autonomic control are the result of the hypertension per 
se. 
This work supports the view that the study of cardiovascular regulation in sleep 
provides fundamental insight on the pathophysiology of hypertension, and may thus 
contribute to the understanding of this disease, which is a major health problem in 
European countries (Wolf-Maier et al., 2003) with its burden of cardiac, vascular, and 
renal complications.  
 
   1 
1. Cardiovascular regulatory 
mechanisms 
 
 
Cardiovascular regulation has multiple levels of control organized hierarchically: 
bottom up local tissue blood flow control mechanisms; autonomic nervous system 
(autonomic reflexes) and finally central nervous system.  
Interactions between local, reflex, and central vascular regulatory mechanisms are 
ubiquitary and complex. Mechanisms involved are often non-linear (Malpas, 2002; 
Ursino & Magosso, 2003), so that it is possible to have divergent results at the level of 
the cardiovascular end-variables measured in similar experiments due to quantitative 
differences in controller or effector responses that shift the balance among interacting 
regulatory mechanisms. Furthermore, there are genetic differences between species and 
groups that may affect the balance among the controls involved and that may explain 
some inconsistencies among experimental results, even if the basic features of 
cardiovascular controls appear constant (Silvani & Lenzi, 2005).  
Mean arterial pressure is the product of two variables: cardiac output and total 
peripheral resistance, which is the sum of the resistance to flow, offered by all the 
systemic blood vessels. Changes in total resistance are mainly due to changes in the 
resistance of arterioles. 
 
 
1.1 Local mechanisms in the control of the circulation 
 
At the lowest level of the cardiovascular regulatory mechanisms there are local 
control mechanisms. Vascular resistance changes as a function of the local physical and 
chemical environment. Therefore, blood flow is relatively independent of perfusion 
pressure (autoregulation), and is coupled to the local rate of energy utilization (flow-
metabolism coupling). This coupling also depends on partial pressures of oxygen and 
carbon dioxide (chemical regulation).  
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1.1.1 Intrinsic regulation of heart activity 
Under most conditions, the amount of blood pumped by the heart each minute is 
determined almost entirely by the rate of blood flow into the heart from the veins 
(venous return). Each peripheral tissue of the body controls its own local blood flow, 
and all the local tissue flows combine and return by way of the veins to the right atrium. 
The heart, in turn, automatically pumps this incoming blood into the arteries, so that it 
can flow around the circuit again. 
This capacity of the heart to adapt to increasing volumes of inflowing blood is called 
Frank-Starling mechanism: within physiological limits, the heart pumps all the quantity 
of blood that returns to it by the way of the veins.  
When an extra amount of blood flows into the ventricles, the cardiac muscle itself is 
stretched to greater length. This in turn causes the muscle to contract with increased 
force because the actin and myosin filaments are brought to a more nearly optimal 
degree of overlap for force generation. So that, the ventricle, because of its increased 
pumping, automatically pumps the extra blood into the arteries (Guyton & Hall, 2005b). 
 
1.1.2 Local control of blood flow in response to tissue needs 
Each tissue has the capacity to control its own local blood flow in proportion to its 
metabolic needs. 
Local blood flow control can be divided into two phases: long-term control and acute 
control. Long-term control means slow, controlled changes in flow over a period of 
days or weeks, and it is achieved by an increase or decrease in the physical sizes and 
numbers of actual blood vessels supplying the tissues. This type of regulation is 
important when the long-term metabolic demands of a tissue changes. Thus, if a tissue 
becomes chronically overactive and therefore requires chronically increased quantities 
of oxygen and other nutrients, the arterioles and capillary vessels usually increase both 
in number and size to match the need of the tissue-unless the circulatory system has 
become pathological or too old to respond (Guyton & Hall, 2005c). 
Acute control is achieved by rapid changes in local vasodilatation or vasoconstriction 
of the arterioles, metarterioles, and precapillary sphincters, occurring within seconds to 
minutes to provide very rapid maintenance of appropriate local tissue blood flow. There 
are two theories for the acute control: the vasodilatators theory and the nutrient lack 
theory. The first one said that the greater the rate of metabolism or the less the 
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availability of oxygen or some other nutrients to a tissue, the greater the rate of 
formation of vasodilator substances (i.e. adenosine, carbon dioxide, adenosine 
phosphate compounds, histamine, potassium ions) in the tissue cells. Vasodilatators 
substances diffuse trough tissues to precapillary sphincters, metarterioles, and arterioles 
to cause dilatation.  
The latter theory said that oxygen and other nutrients are required to cause vascular 
muscle contraction. Without adequate oxygen, the blood vessels simply would relax and 
therefore naturally dilate. In addition, increased utilization of oxygen in the tissues for 
increased metabolism could decrease the availability of oxygen in the smooth muscle 
fibers in the local blood vessels, and this too, would cause local vasodilatation. In fact, 
smooth muscle requires oxygen to remain contracted, and the strength of contraction of 
the sphincters would increase with an increase in oxygen concentration. So that, when 
the oxygen concentration in the tissue rises above a certain level, the precapillary and 
metarteriole sphincters presumably would close until the tissue cells consume the excess 
oxygen. But when the excess oxygen is gone and the oxygen concentration falls low 
enough, the sphincters would open once more to begin the cycle again. 
Either vasodilatators substance theory or nutrient lack theory could explain acute local 
blood flow regulation in response to the metabolic needs of the tissues and probably the 
truth lies in a combination of the two mechanisms (Guyton & Hall, 2005c). 
In certain tissues, blood flow is adjusted to the existing metabolic activity of the 
tissue. But, within less than a minute, the blood flow in most tissues returns almost to 
the normal level even thought the arterial pressure is kept elevated. This mechanism is 
commonly referred to as ‘autoregulation’ of blood flow. Why blood flow remains 
constant in presence of an altered perfusion pressure may be explained by the metabolic 
regulation or by the myogenic mechanism. The first one suggests that when the arterial 
pressure becomes too great, the excess flow provides too much oxygen and too many 
other nutrients to the tissues. These nutrients cause the blood vessel to constrict and the 
flow to return nearly to normal despite the increased pressure. The latter is based on the 
observation that sudden stretch of small blood vessels causes the smooth muscle of the 
vessel wall to contract for a few seconds. So that, when high arterial pressure stretches 
the vessels, this in turn causes reactive vascular constriction that reduces blood flow 
nearly back to normal. Conversely, at low pressure, the degree of stretch of the vessel is 
less, so that the smooth muscle relaxes and allows increased flow (Berne & Levy, 
2005d; Guyton & Hall, 2005c). 
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1.2 Autonomic nervous system in the control of the 
cardiovascular function 
 
The intermediate level of cardiac and vascular control is exerted by autonomic 
reflexes, which originate from peripheral tissues and from the cardiovascular system 
itself. The neural control of the cardiovascular system is accomplished by the autonomic 
outflow to the heart, through sympathetic and parasympathetic drives, and to the vessels 
by sympathetic drive. Autonomic outflow also comprises either reflex contribution of 
peripheral factors (baroreceptors, chemoreceptors, and thermoreceptors) or central 
commands that change as a function of the behavioural state, such as the wake-sleep 
states, the defence reaction, and emotional states. 
To the homeostasis contributes the integrated reflex control of the cardiovascular and 
ventilatory functions that allows an effective buffering of alterations in systemic arterial 
pressure, arterial blood gas concentration, and body temperature (Silvani & Lenzi, 
2005). 
The nervous system controls the circulation almost entirely through the autonomic 
nervous system; by far the most important part of the autonomic nervous system for 
regulating the circulation is the sympathetic nervous system; the parasympathetic 
nervous system also contributes specifically to regulation of heart function (Guyton & 
Hall, 2005d). 
 
1.2.1 Sympathetic innervation of blood vessels 
In most tissues, sympathetic nerve fibers innervate all the vessels except the 
capillaries, precapillary sphincters, and metarterioles. The innervation of small arteries 
and arterioles allows to increase resistance to blood flow and thereby to decrease rate of 
blood flow through tissues; the innervation of large vessels, particularly veins, makes it 
possible to decrease the volume of the vessels; so that blood is pushed into the heart and 
in this way sympathetic stimulation may play a role in the regulation of heart pumping 
(Guyton & Hall, 2005d).  
These vasoconstrictor fibers are distributed to essentially all segments of the 
circulation, but more to some tissues than others. They are most abundant in the 
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kidneys, skin, intestines, spleen, relatively sparse in the coronary and cerebral vessels 
and skeletal muscle (Boulpaep, 2003; Guyton & Hall, 2005d).  
The transmitter secreted at the endings of the vasoconstrictor nerves is almost entirely 
norepinephrine. Norepinephrine acts directly on the  adrenergic receptors on the 
membrane of vascular smooth-muscle cells to cause vasoconstriction (Boulpaep, 2003; 
Guyton & Hall, 2005d). 
 
1.2.2 Control of the heart by parasympathetic and 
sympathetic nerves 
The pumping effectiveness of the heart is controlled by both the divisions of the 
autonomic nervous system, which abundantly supply the heart. Sympathetic and 
parasympathetic nerves tonically influence the cardiac pacemaker, the sinoatrial node: 
the sympathetic one enhances automaticity, whereas the parasympathetic one inhibits it. 
Changes in heart rate usually involve a reciprocal action of these two divisions of the 
autonomic nervous system: the heart rate usually increases with a combined decrease in 
parasympathetic activity and an increase in sympathetic activity; the heart rate decreases 
with the opposite changes in autonomic neural activity, even if parasympathetic tone 
ordinarily predominates in healthy, resting individuals (Berne & Levy, 2005c; Guyton 
& Hall, 2005b).  
 
Parasympathetic pathways 
The cardiac parasympathetic fibers originate in the medulla oblongata, in particular in 
the cells that lie in the dorsal motor nucleus of the vagus or in the nucleus ambiguous. 
The precise location of the parasympathetic fibers varies from species to species (Berne 
& Levy, 2005c). Most of the vagal ganglion cells are spotted in epicardial fat pads near 
the sinoatrial and atrioventricular nodes (Berne & Levy, 2005c) and not much to the 
ventricles, where the power contraction of the heart occurs. This explains the effect of 
vagal stimulation mainly to decrease heart rate rather than to decrease greatly the 
strength of heart contraction (Guyton & Hall, 2005b).  
The right and left vagi are differently distributed to cardiac structures, even if the 
distribution of the efferent vagal fibers is overlapping. The right vagus nerve affects the 
sinoatrial node particularly and the stimulation of this nerve slows sinoatrial nodal firing 
and can even stop the firing for a few seconds, but then the heart usually ‘escapes’ and 
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beats at a rate of 20 to 40 beats per minute as long as the parasympathetic stimulation 
continues; the left vagus nerve mainly inhibits atrioventricular conduction tissue to 
produce various degrees of atrioventricular block (Berne & Levy, 2005c; Guyton & 
Hall, 2005b).  
The vagus normally exerts an intense tonic, parasympathetic activity on the heart via 
acetylcholine released by the postganglionic fibers. Acetylcholine is rapidly hydrolyzed 
by the cholinesterase enzyme, which are abundant the sinoatrial and atrioventricular 
nodes. Owing to this rapid breakdown of the enzyme, the effects of any given vagal 
stimulation decay very quickly, when vagal stimulation is discontinued. Furthermore, 
the effects of vagal activity on sinoatrial and atrioventricular nodal function have a very 
short latency (50-100ms), because the released acetylcholine quickly activates special 
acetylcholine-regulated K+ channels in the cardiac cells that do not need an intermediate 
second messenger system. In this way, brief latency and rapid decay of response permits 
these nerves to exert a beat by beat control of sinoatrial and atrioventricular nodal 
functions (Boulpaep, 2003; Berne & Levy, 2005c). 
 
Sympathetic pathways 
The cardiac sympathetic fibers originate in the intermediolateral columns of the upper 
five or six thoracic and lower one or two cervical segments of the spinal cord. When the 
postganglionic cardiac sympathetic fibers approach the base of the heart along the 
adeventitial surface of the great vessels, these fibers are distributed to the various 
chambers as an extensive epicardial plexus. Then they penetrate the myocardium, 
usually accompanying the coronary vessels and innervate sinoatrial node, atria and 
ventricles(Berne & Levy, 2005c). 
As with the vagus nerve, the left and right sympathetic fibers are distributed to 
different areas of the heart. Sympathetic input from the right cardiac nerve has more 
effect on the heart rate than input from the left cardiac nerve, because it dominates the 
innervation of the sinoatrial node. On the other hand, sympathetic input from the left 
cardiac nerve has more effect on contractility. At rest, their firing rate is less than that of 
the vagus nerve (Boulpaep, 2003). 
Norepinephrine is released by the postganglionic sympathetic neurons and acts on 
postsynaptic 1-adrenergic receptors of pacemaker cells in the sinoatrial node, as well as 
on similar receptors of myocardial cells in the atria and ventricles. The 1 adrenoceptor, 
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via the G-protein Gs, acts via the cyclic adenosine monophosphate-protein kinase A 
pathway to phosphorilate multiple effector molecules in both pacemaker cells and 
cardiac myocytes (Boulpaep, 2003). 
The effects of sympathetic stimulation decay only gradually after stimulation is 
stopped, in contrast to the abrupt termination of the response to vagal activity. Nerve 
terminals take up most of the norepinephrine released during sympathetic stimulation, 
and much of the remainder is carried away by the bloodstream. All these processes are 
slow. Furthermore, at the beginning of sympathetic stimulation, the facilitatory effects 
on the heart attain steady-state values much more slowly than do the inhibitory effects 
of vagal stimulation. 
The onset of the cardiac response to sympathetic stimulation is slow for two main 
reasons: first, norepinephrine is released at a relatively slow rate from the cardiac 
sympathetic nerve terminals; second, the cardiac effects of the neurally released 
norepinephrine are mediated mainly via a slow second messenger system (principally 
the adenylyl cyclase system). As a result, sympathetic activity modifies heart rate and 
atrioventricular conduction much more slowly than does vagal activity. Hence, unlike 
vagal activity, sympathetic activity can not exert beat by beat control of cardiac function 
(Berne & Levy, 2005c). 
 
 
1.3 Regulation of cardiac output  
 
Cardiac output is defined as the volume of blood pumped by each ventricle per 
minute. It is also the volume of blood flowing through either the systemic or the 
pulmonary circuit per minute. In mathematical terms, cardiac output can be expressed as 
the product of stroke volume, the blood volume ejected by each ventricle with each 
beat, and heart rate, the number of beats per minute. Cardiac output may be varied by 
changing the stroke volume or the heartbeat’s frequency. 
Various factors can produce changes in force of contraction, but there are three main 
elements. The first one is the end-diastolic volume, the volume of blood in the 
ventricles just before contraction. The relationship between the end-diastolic volume 
and stoke volume is determined by the Frank-Starling mechanism: at any given heart 
rate, an increase in venous return, the flow of blood from the veins to the heart, 
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automatically forces an increase in cardiac output by increasing end-diastolic volume 
and thus stroke volume. 
The second factor related to stroke volume is the sympathetic activity to the 
ventricles. Norepinephrine acts on 1-adrenergic receptors in myocardial cells to 
increase the strength of contraction at any given end-diastolic volume. The increase of 
contractility induces to a more complete ejection of the end-diastolic ventricular volume 
and then to an increase in stroke volume. 
The third factor that influences stroke volume is afterload, the arterial pressure against 
which the ventricles pump. An increase in afterload tends to reduces stroke volume 
(Widmaier et al., 2004). 
Cardiac output is also influenced by heart rate, but this relation is much more complex 
because a change in heart rate may alter also other factors (contractility, afterload, end-
diastolic volume). So that since the stroke volume tends to decrease as heart rate 
increases, the cardiac output vs. heart rate function shows a characteristic inverted U 
shape. However, this relationship varies quantitatively among subjects and among 
physiological states in any given subject (Berne & Levy, 2005a). 
 
 
1.4 Short and long-regulation of arterial pressure 
 
The arterial baroreceptor play a key role in short-term adjustments of blood pressure in 
response to a relatively abrupt changes in blood volume, cardiac output, or peripheral 
resistance (as in exercise or in alarm reaction). However, long-term control of blood 
pressure, over days or weeks, is determined by the fluid balance of the individual. The 
most important organ in the control of body fluid volume and hence of blood pressure is 
the kidney. 
 
Short-regulation of arterial pressure 
There are multiple nervous control mechanisms that operate all the time to maintain 
the arterial pressure at or near normal. By far the best known of the nervous 
mechanisms for arterial pressure control is the baroreceptor reflex, a negative feedback 
reflex mechanism.  
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Changes in arterial pressure induce deformation of the vessels and then changes in the 
arterial wall tension, which are sensed by baroreceptors. Baroreceptors are stretch 
receptors, located in the wall of each internal carotid artery slightly above the carotid 
bifurcation (carotid sinus) and in the wall of the aortic arch. Impulses that arise in the 
carotid sinus travel up the carotid sinus nerve (nerve of Hering) to the glossopharyngeal 
nerve and, via the latter, to the nucleus of the tractus solitarius in the medulla. Signals 
from the aortic baroreceptors are transmitted through the vagus nerves also to the same 
tractus solitarius of the medulla. 
The frequency of firing of the baroreceptor nerve terminals is enhanced by an increase 
in arterial blood pressure and diminished by a reduction in arterial blood pressure. An 
increase in impulse frequency, as occurs with a rise in arterial pressure, inhibits the 
vasoconstrictor center of the medulla and excites the vagal parasympathetic center. The 
net effects are peripheral vasodilatation and decreased heart rate and strength of heart 
contraction. So that, activation of the baroreceptors by high pressure causes the arterial 
pressure to decrease because of both a decrease in peripheral resistance and a decrease 
in cardiac output. Conversely, low pressure has opposite effects, reflexly causing the 
pressure to rise back toward normal values (Berne & Levy, 2005d; Guyton & Hall, 
2005d). 
The arterial baroreceptors provide powerful moment-to-moment control of arterial 
pressure and tend to reset in 1 to 2 days to the pressure level to which they are exposed, 
so they have little or no importance in long term regulation of mean arterial pressure. 
Experimental studies, however, have suggested that the baroreceptors do not completely 
rest and may therefore contribute to long-term blood pressure regulation, especially by 
influencing sympathetic nerve activity of the kidneys (Malpas, 2004). 
In hypertension, baroreceptor sensitivity decreases, because the carotid sinuses 
become stiffer as a result of the high arterial pressure. In fact, the set point of the 
baroreceptor is raised in hypertension, such that the threshold is increased and the 
pressure receptors are less sensitive to changes in transmural pressure. 
As would be expected, sino-aortic denervation can produce temporary or prolonged 
hypertension (Berne & Levy, 2005d; Guyton & Hall, 2005d). 
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Long-regulation of arterial pressure 
The baroreceptor mechanisms are of great importance for the moment-to-moment 
stabilization of arterial pressure, but because they do not possess sufficient strength and 
because they reset in time to the prevailing level of arterial pressure, they cannot 
provide a sustained negative feedback signal to provide long-term regulation of arterial 
pressure in face of sustained stimuli (Cowley, 1992). The body, however, also has 
powerful mechanisms for regulating arterial pressure week after week and month after 
month, in particular the renin-angiotensin cascade, which is a neurohumoral mechanism 
that regulates the effective blood volume. 
Renin is a protein enzyme released by the kidneys in response to a reduction in arterial 
pressure. This enzyme is synthesized and stored in an inactive form (prorenin) in the 
juxtaglomerular cells, modified smooth muscle cells located in the walls of the afferent 
arterioles immediately proximal to the glomeruli, in the kidneys. When arterial pressure 
falls, intrinsic reactions in the kidneys themselves cause many of the prorenin molecules 
in the juxtaglomerular cells to split and release renin. Renin enters in the bloodstream, 
but a small amount remains in the local fluid of the kidneys. 
Renin acts enzymatically on a globulin called angiotensinogen, another plasma protein, 
to release a peptide, angiotensin I. Angiotensin I has bland vasoconstrictor proprieties, 
and it is eventually converted to angiotensin II in the endothelium of lung vessels by an 
enzyme called angiotensin converting enzyme (ACE). Angiotensin II persists in the 
blood only 1 or 2 minutes after which it is inactivated by angiotensinases. 
Angiotensin II is a powerful vasoconstrictor in many areas of the body: 
vasoconstriction of the arterioles increases the total peripheral resistance, thereby 
raising the arterial pressure; moreover, angiotensin II stimulates aldosterone secretion 
by the adrenal gland, which increases both salt and water reabsorption by the kidneys 
tubules, thus increasing the total body extracellular fluid volume and leading 
secondarily to long-term elevation of arterial pressure (Guyton et al., 1972). Thus the 
renin-angiotensin system is an automatic feedback mechanism that helps maintain 
arterial pressure at or near the normal level even when salt intake is changed; 
conversely, opposite effects take place, when salt intake is decreased below normal 
(Guyton & Hall, 2005a). 
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1.5 Central nervous system in the control of the 
circulation 
 
The highest level of cardiovascular control is exerted by the central nervous system, 
which imposes autonomic commands (Spyer, 1994) on cardiac, vascular, and 
ventilatory effectors and overriding the levels of local and reflex regulation. Therefore, 
autonomic commands mediate a feedforward control mechanism that prevails 
temporally over negative feedback controls. Central nervous system, with central 
autonomic commands, anticipates the needs of the organism, increasing blood pressure 
and heart rate so that a blood pressure drop is prevented during a subsequent physical 
activity. As in physical exercise or in defence reaction, central autonomic commands 
contribute to adapt cardiovascular regulation to changing behavioural needs (Berne & 
Levy, 2005b).  
 
1.5.1 Physical exercise 
In humans or trained animals, at the beginning of physical exercise, the vagal nerve 
impulses to the heart are inhibited, whereas the sympathetic discharge is increased. The 
simultaneous inhibition of parasympathetic areas and activation of sympathetic areas 
augment heart rate and myocardial contractility. As a result, the tachycardia and 
enhanced contractility increase cardiac output. 
Concomitantly with cardiac stimulation, the sympathetic nervous system changes 
vascular resistance in the periphery. In splanchnic regions, skin, kidneys and inactive 
muscles, vasoconstriction increases vascular resistance and diverts blood away from 
these areas. Blood flow to the myocardium increases, whereas flow to the brain is 
unchanged. Skin blood flow initially decreases during exercise, and then it increases as 
body temperature rises with increments in the duration an intensity of exercise. 
The major cardiovascular adjustment to exercise occurs in the vasculature of the 
active muscles. Local formation of vasoactive metabolites causes a decrease in the total 
peripheral resistance and enables an increase in venous return and cardiac output. 
At rest only a small percentage of the capillaries are perfused, but during exercise 
nearly all of the capillaries contain flowing blood (capillary recruitment). In this way, 
the surface area available for exchange of gases, water, solutes is increased many times. 
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Arterial pressure starts to rise with the onset of the exercise as a result of the increase 
in cardiac output. Therefore, the increase in cardiac output is proportionally greater than 
the decrease in total vascular resistance. Furthermore, the vasoconstriction produced in 
the inactive tissues by the sympathetic nervous system is fundamental for maintenance 
of normal or increased blood pressure. Experiments show that sympathectomy or drug-
induced block of the adrenergic sympathetic nerve fibers determine hypotension during 
exercise (Berne & Levy, 2005b). 
Central commands interact with baroreceptor reflex in controlling the cardiovascular 
system at the onset of exercise. The operating point of the arterial baroreflex is not 
fixed, but is variable over a wide range of pressures and is determined by a variety of 
inputs from the peripheral and central nervous systems. The initial increase in heart rate 
and sympathetic nerve activity, during physical exercise, is mediated by central 
command. This command operates by resetting the operating point of the arterial 
baroreflex to a higher pressure (DiCarlo & Bishop, 2001; Silvani & Lenzi, 2005). Other 
experiments show a reduction in the baroreflex sensitivity at the operating point as a 
result of vagal withdrawal rather than an increase in sympathetic activity (Ogoh et al., 
2005).  
 
1.5.2 Defence reaction 
A complex set of somatic and autonomic responses, called defence reaction, is 
triggered by dangerous situations that may require the organism to fight or flight. This 
reaction may also be experimentally caused by electrical stimulation of the 
mesencephalic tectum in rats (Schenberg et al., 1993) and involves an increase in 
sympathetic activity to heart and vessels. In this way, the organism undergoes an 
anticipatory increase in arterial pressure rather than waiting for the baroreflex to buffer 
the hypotension, which would follow muscle activity during fight or flight and would 
hamper the effectiveness of such vital behaviours (Guyton & Hall, 2005d).  
The defence reaction obtained by electrical stimulation in rats (Schenberg et al., 
1993), shows that the baroreflex interacts with central commands in determining the 
cardiovascular changes that characterize this condition. Electrical stimulation produced 
stimulus intensity-dependent behaviours including freezing at lower intensities and 
flight at higher intensities. Simultaneous increases of mean arterial blood pressure and 
heart rate is seen at the beginning of the flight response, after which heart rate rapidly 
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falls to baseline levels, consistently with a late baroreflex dampening, whereas the mean 
arterial blood pressure remained at an hypertensive level until the end of the stimulus. 
Experiments with sinoaortic baroreceptor denervated rats corroborate these data. The 
denervation strengthens flight tachycardia and prevents its later reset, but mean blood 
arterial pressure responses of baroreceptor denervated rats do not differ from non 
denervated rats. The sustained hypertension, thus, appears to be mediated by 
mechanisms other than the mere baroreceptor reflex deactivation.  
 
 
1.6 Spontaneous fluctuations in heart period and blood 
pressure 
 
Spontaneous oscillations in cardiovascular variables, such as arterial pressure and 
heart rate, can be observed in experimental animals and in human and fluctuate on a 
beat to beat basis. These fluctuations have traditionally been ignored or, at best, treated 
as noise to be averaged out. It is unknown whether these fluctuations subserve a 
physiological need; however they are generated and shaped by cardiovascular and 
respiratory systems and by their control mechanisms. In this way these fluctuations give 
information on the physiology and pathophysiology of the systems that generate and 
modulate them. The variability in cardiovascular signals reflects the homeodynamic 
interplay between perturbations to cardiovascular function and the dynamic response of 
the cardiovascular regulatory systems (Appel et al., 1989). 
The information conveyed by spontaneous cardiovascular variability is valuable 
because it may be obtained non-invasively, without perturbing the behavioural state of 
the subject; it pertains to the working point of the cardiovascular and respiratory 
systems; and it allows non-linear regulatory systems to be approximated by simpler 
linear systems, because of the small amplitude of spontaneous oscillations. However, it 
is important to underline that not all changes in cardiovascular variability are indicative 
of changes in autonomic function (Malpas, 2002). 
The relationship between heart period, the reciprocal of heart rate, and blood pressure 
changes as a function of the frequency range of the cardiovascular fluctuations 
analyzed. Spontaneous oscillations of heart period and arterial pressure can be analysed 
by mathematical tools to extract the main frequency-related information. This is 
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generally contained within three principal bands: a high-frequency band, related to the 
respiratory rate; a low-frequency band, centred around 0.1 Hz in human subjects 
(Malliani et al., 1991; Sleight et al., 1995) and 0.4 Hz in rats (Brown et al., 1994); and a 
very-low-frequency band, spanning the leftmost part of the spectrum, but typically 
around 0.05 Hz (Cevese et al., 2001). 
Variability in blood pressure around the breathing rate can be explained on the basis 
of the cyclic variation in intrathoracic pressure associated with breathing, which affect 
cardiac output via changes in venous return and thus blood pressure (Malpas, 2002). 
Therefore, the high-frequency variability of blood pressure is not substantially modified 
in patients with denervated human heart (Bernardi et al., 1989). 
Rhythmic variations in heart rate, occurring at the frequency of respiration, are called 
respiratory sinus arrhythmia and are detectable in most subjects. At rest, heart rate tends 
to accelerate during inspiration and decelerates during expiration (Saul et al., 1989). 
Recordings from the autonomic nerves to the heart reveal that neural activity increases 
in the sympathetic fibers during inspiration, whereas neural activity in the vagal fibers 
increases during expiration (Kollai & Koizumi, 1979). Vagal nervous system is known 
to participate in respiratory sinus arrhythmia, both by means of a central coupling with 
the neural centres that control breathing and through the baroreflex (Malpas, 2002). So 
that, respiratory oscillations in heart rate and blood pressure are not determined only by 
the baroreceptor reflex. Accordingly, after sino aortic deafferentation in cats, rats or 
dogs, the spectral power density of blood pressure fluctuations in the high-frequency 
band is not substantially changed (Di Rienzo et al., 1991; Cerutti et al., 1994). In human 
subjects, respiratory sinus arrhythmia can actually contribute to respiratory arterial 
pressure fluctuations. Therefore, respiratory sinus arrhythmia does not represent simple 
baroreflex buffering of arterial pressure (Taylor & Eckberg, 1996).  
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2. Sleep 
 
 
Sleep is a complex amalgam of physiologic and behavioural processes, the control 
mechanisms of which are manifested at every level of biological organization, from 
genes and intracellular mechanisms to networks of cell populations, and to all central 
neuronal systems at the organismic level, including those that control movement, 
arousal, autonomic functions, behaviour and cognition (Pace-Schott & Hobson, 2002). 
It is a state of immobility with greatly reduced responsiveness, which can be 
distinguished from coma or anaesthesia by its rapid reversibility. When it is prevented, 
the body tries to recover the lost amount: the existence of sleep ‘rebound’ after 
deprivation demonstrates that sleep is not simply a period of reduced activity or 
alertness regulated by circadian or ultradian rhythms (Carskadon & Dement, 2005; 
Siegel, 2005). 
In mammals and birds, there are two types of sleep: non rapid-eye-movement 
(NREM) sleep and rapid-eye-movement (REM) sleep. They are defined in terms of 
electrophysiological signs that are detected with a combination of 
electroencephalography (EEG), electroculography (EOG) and electromyography 
(EMG), the measurement of which in humans is collectively termed polysomnography 
(Rechtschaffen & Kales, 1968). 
 
 
2.1 From wakefulness to sleep 
 
When relaxed with eyes closed, the majority of humans show an EEG of rhythmic  
activity (in the range of 8-13 Hz) and the EMG shows tonic activity of a relatively high 
level. When a person is awake, control of eye movements is voluntary: the waking EOG 
tracing generally consists of rapid eye movements and eye blinks, when the eyes are 
open, and few or no eye movements, when the eyes are closed. Involuntary slow, rolling 
eye movements, with eyes closed, often characterize the EOG in the seconds to minute 
preceding the EEG change to stage I sleep (Carskadon & Rechtschaffen, 2005).  
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The precise definition of the onset of sleep does not exist, because a change in EEG 
pattern is not always associated with an individual’s perception of sleep. The onset of 
sleep under normal circumstances in normal adult humans is through NREM sleep 
(Carskadon & Dement, 2005) and NREM and REM sleep alternate in each of the four 
or five cycles that occur in each night. Early in the night, NREM sleep is deeper and 
occupies a disproportionately large amount of time, especially in the first cycle, when 
the REM epoch might be short or aborted. Later in the night, NREM sleep is shallow, 
and more of each cycle is devoted to REM. 
The cyclic organization of sleep varies within and between species. In fact, the period 
length of each REM–NREM epoch increases with brain size across species, and the 
depth and proportion of the NREM phase in each cycle increases with brain maturation 
within species. NREM sleep complexity is a function of brain systems, such as the 
thalamocortical circuitry, that reach their maximum development in mature humans 
only to decline in post-mature age (Pace-Schott & Hobson, 2002). 
In humans, the average length of the first NREM-REM sleep cycle is approximately 70 
to 100 minutes; the average length of the second and later cycles is approximately 90 to 
120 minutes. Across the night, the average period of the NREM-REM cycle is 
approximately 90 to 110 minutes (Carskadon & Dement, 2005). 
 
 
2.1.1 NREM sleep 
A shorthand definition of NREM sleep is a relatively inactive, yet actively regulating 
brain in a movable body (Carskadon & Dement, 2005). NREM sleep or slow wave 
sleep (SWS) is easily distinguishable from both wakefulness and REM sleep by high 
voltage and synchronous EEG rhythms (Steriade, 2005).  
In human, NREM sleep is divided into four stages, corresponding to increasing depth 
of sleep, as indicated by progressive dominance of the EEG by high-voltage, low-
frequency ('synchronized') wave activity. Such low-frequency waves dominate the 
deepest stages of NREM (stages III and IV). The four NREM stages (stages I, II, III, 
IV) roughly parallel a depth of sleep continuum, with arousal thresholds generally 
lowest in stage I and highest in stage IV sleep. NREM sleep is associated with 
fragmentary mental activity (Carskadon & Dement, 2005).  
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In the stage I there is a relatively low voltage, mixed-frequency EEG activity; vertex 
sharp waves are common during stage I sleep occurring at the beginning of the night. 
The EEG activity is generally in the  range (3-7 Hz); muscle tone is maintained during 
all NREM sleep stages and registers as low-amplitude EMG activity (Carskadon & 
Rechtschaffen, 2005), but there is a gradual decline in muscle tone (hypotonia) during 
NREM sleep compared with that during wakefulness (Chase & Morales, 2005).  
In the stage II there is a relatively low voltage, mixed-frequency EEG activity. There 
are two specific EEG patterns that occur sporadically on this mixed-frequency 
background and enable to distinguish stage II from stage I: the sleep spindle and the K-
complex. Sleep spindles have a waxing and waning spindle shape, composed of waves 
in the range of 12-14 Hz, with a duration of about 0.5-1.5 seconds (Carskadon & 
Rechtschaffen, 2005). Sleep spindles are a common feature of mammalian sleep and are 
generated in the thalamus, but the cerebral cortex plays a major role in their 
synchronization and virtually simultaneous appearance over widespread thalamic and 
cortical areas (Steriade, 2005). The K-complex consists of a “well delineated negative 
sharp wave which is immediately followed by a positive component. The total duration 
of the complex should exceed 0.5 second” (Rechtschaffen & Kales, 1968). K-complexes 
occur spontaneously during stage II sleep and are also evoked in response to auditory 
stimuli. The EMG during stage II sleep is tonically active, generally at low amplitude 
relative to wakefulness. 
The EEG of stages III and IV sleep is defined by the presence of high-voltage, slow 
wave activity. Stage III is composed of waves of 2 Hz or slower and in stage IV such 
waves predominate (more than 50% of the epoch); EMG is tonically active, but at a low 
level (Carskadon & Rechtschaffen, 2005) (see Figures 2.1 and 2.2). 
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Figure 2.1. Sleep cycle. Panel a shows the characteristic waveforms of the different sleep stages; panel b 
illustrates changes over the course of a night's sleep; panel c shows changes in peripheral physiology 
associated with these stages. REM sleep is indicated by red bars. Panel a depicts, in detail, features of an 
early-night sleep cycle in which NREM reaches its greatest depth at stage III and IV (delta) sleep, 
whereas panel c depicts a late-night cycle in which NREM descends only to stage III. The constant period 
length of the NREM–REM cycle indicates that it is timed by a reliable oscillator, the amplitude of which 
varies according to extrinsic factors. From (Pace-Schott & Hobson, 2002). 
 
 
2.1.2 REM sleep 
A shorthand definition of REM sleep is a highly activated brain in a paralyzed body 
(Carskadon & Dement, 2005). 
Staging REM sleep (or paradoxical sleep) requires the coincidence of specific 
activities in all three electrographic measures: ‘activated’ or desynchronized EEG, 
bursts of rapid eye movements in the EOG and suppression of EMG activity. The REM 
sleep EEG pattern is characterized as one of relatively low voltage, mixed frequency. 
An EEG pattern called sawtooth waves, with frequency in  range, is fairly common 
during REM sleep, particularly in proximity to eye movements. Activity in the  range 
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(1-2 Hz slower than waking  activity) may also be seen in the REM sleep EEG 
(Carskadon & Rechtschaffen, 2005). 
The desynchronization of the EEG pattern during REM sleep and also during waking 
means the disruption of high-amplitude and synchronous EEG waves and the 
replacement of low-frequency oscillation by fast rhythm with lower amplitude. 
However, during REM sleep and also during wakefulness, the spontaneously occurring 
fast rhythms (20 to 50 Hz, called  and ) are synchronized over restricted distances in 
the cortex as well as among cortical areas and related thalamic nuclei. Thus, it is 
preferable to use the term ‘activation’ than ‘desynchronization’ to define the brain 
electrical activity during REM sleep and waking (Steriade, 2005).  
The paradox that a similar EEG activity characterizes two states of vigilances 
(wakefulness and REM sleep) that are at the opposite sides of the sleep-waking cycle 
suggests that, with regard to brain cellular activities, waking and REM sleep are closer 
than is usually believed. In this regard, both states show distinct differences from 
NREM sleep, which is characterized by widely syncronized brain electrical activity 
(Steriade, 2005).  
Other striking features of REM sleep are ponto-geniculo-occipital (PGO) spikes in 
feline (Jouvet, 1967) and rhythmic  activity (4-8 Hz), originating in the hippocampus, 
in many primates, cats, dogs and rodents. In these latter it can be recorded with 
implanted epidural electrodes over the parietal or occipital cortex (Zepelin et al., 2005).  
An universal feature of REM sleep in intact organism is the tonic suppression of 
skeletal muscle tone (atonia) and reflexes via a circuit that involves pontine activation 
of medullary inhibitory centers by neurotransmitter glycine and culminates in 
postsynaptic hyperpolarization of brainstem and spinal motoneurons. Superimposed on 
this background of tonic motor inhibition occasional twitches and jerks of distal 
muscles can be seen. Twitches occur due to excitatory processes (postsynaptic 
potentials) that impinge on motoneurons; but, even during these periods of excitatory 
potentials, motoneurons continue to be inhibited by glycine. Therefore, during REM 
sleep, there is tonic inhibition of motoneurons, as well as phasically occurring brief 
periods of motoneuron excitation (Chase, 1983; Chase & Morales, 2005). In human 
twitches appear as very short-lived EMG elevations, usually in proximity to eye 
movement bursts and in other species, paws, face, whiskers show twitches during REM 
sleep. 
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REM sleep is not divided into stages, although tonic and phasic types of REM sleep 
are often distinguished. The marker of REM sleep phasic activity is the burst of rapid 
eye movements, which are often accompanied by muscle twitches and cardiorespiratory 
irregularities (see Figures 2.1 and 2.2). 
 
 
 
Figure 2.2. Two cortical EEG, hippocampal EEG, electromyogram (EMG) and electro-oculogram (EOG) 
during wakefulness, NREM sleep and REM sleep in cats. From (Jouvet, 1967). 
 
 
2.2 Homeostasis and physiologic regulation in sleep 
 
In mammals, sleep is under homeostatic control. The principle of homeostasis in 
physiology was defined by W.B. Cannon in 1929 as “the coordinated physiologic 
processes which maintain most of the steady states in the organism” (Cannon, 1929). 
Physiologic homeostasis is effected by feedforward and feedback operations that 
predictively and reactively minimize the influences of internal and external disturbances 
on the organism. This means that it is necessary to verify whether effector activity 
maintains (homeostasis) or impairs (poikilostasis) the stability, the normal range, of the 
fundamental variables of the interstitial and cellular compartments (temperature, water 
volume, electrolytes, osmolarity, pH, nutrients, oxygen, carbon dioxide) that underlie 
cellular survival. The homeostasis of such variables is the eventual result of continuous 
adjustments of “instrumental” variables (heart rate, ventilation, blood pressure, muscle 
force, vascular resistance, cardiac output, stroke volume) that are directly affected by 
the activity of somatic and visceral effectors. 
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Homeostatic regulation of physiologic function depends on the sleep-wake cycle and 
this dependency is the result of changes in the functional dominance of different brain 
structures in different behavioural states (Parmeggiani, 2005). 
A basic difference between NREM sleep and REM sleep is the functional similarity of 
the former in different species and the functional variety and variability of the latter 
within and between species. The basic somatic features of NREM sleep are the 
assumption of a thermoregulatory posture and a decrease in muscle activity; the basic 
autonomic feature of this state is the functional prevalence of parasympathetic 
influences over the sympathetic activity. These peculiarities are indicative of closed-
loop operations that automatically maintain homeostasis at a lower level of energy 
expenditure compared with that in wakefulness and the leading neural structures are 
diencephalic. Conversely, the basic somatic features of REM sleep are muscle atonia, 
rapid eye movements and myoclonic twitches; the basic autonomic feature of REM 
sleep is the great variability in sympathetic activity and phasic changes in tonic 
parasympathetic discharge (Parmeggiani, 2005). The somatic and visceral phenomena 
of REM sleep are characterized by the greatest variability as a result of open-loop 
operations of central origin, which impair the homeostasis and the leading neural 
structures are rhomboencephalic (Parmeggiani, 1980). 
This basic functional dichotomy may be also applied to the nervous control of body 
temperature and of circulatory and respiratory functions. 
 
 
2.3 Control of body temperature 
 
During NREM sleep thermoregulatory mechanisms are operative as they are in 
wakefulness, despite some state-differences in the threshold and gain of effector 
responses to thermal loads and down-regulation, together with energy expenditure, of 
body and hypothalamic temperatures. Homeothermy, in mammals, is controlled by 
preoptic-hypothalamic integrative mechanisms that drive subordinate brainstem and 
spinal somatic and visceral mechanisms that elicit thermoregulatory effector responses 
(Parmeggiani, 2005). 
The thermoregulatory responses to ambient thermal loads are present during NREM 
sleep and absent or depressed during REM sleep. During NREM sleep cat’s posture, for 
   22 
example, clearly varies in relation to ambient temperature, while the drop in postural 
muscle tone during REM sleep is unrelated to ambient temperature (Parmeggiani & 
Rabini, 1970). Warm temperature notwithstanding, tachypnea in cat and heat-exchange 
vasodilatation in cat, rabbit and rat disappear and sweating in humans decreases during 
REM sleep. In a similar way with a cold temperature, shivering and piloerection in cat, 
heat-exchange vasoconstriction in cat, rabbit and rat are suppressed during REM sleep. 
Events in REM sleep are not only simply the result of state-dependent changes in 
threshold and gain of the different thermoregulatory responses; REM sleep is 
characterized by effector activity that is not only functionally inconsistent with the aim 
of temperature regulation but also lacks any proportional relationship with the intensity 
of the thermal stimulus. The conclusion is that the temperature of the body changes 
according to its thermal inertia, like in a poikilothermic organism (Parmeggiani, 2005). 
 
 
2.4 Circulatory function 
 
Sleep states exert a major impact on circulatory function and this is a direct 
consequence of the significant variations in the brain states that occur in the normal 
cycling between NREM and REM sleep. 
On the whole, NREM sleep is depicted by a relative autonomic stability and 
functional coordination between respiration, pumping action of the heart, and 
maintenance of arterial blood pressure (Verrier et al., 2005). The cardiovascular 
changes in NREM sleep are consistent with the changes in ventilation and 
thermoregulation in a condition of postural and motor quiescence (Parmeggiani, 2005). 
NREM sleep is characterized by a down regulation of cardiovascular activity of 
variable intensity depending on the species and its previous level in wakefulness 
(Parmeggiani, 2005), with vagal nerve dominance and heightened baroreceptor gain 
(Verrier et al., 2005). In fact, relative to the values in wakefulness, NREM sleep entails 
hypotension, bradycardia, and a reduction in cardiac output and systemic vascular 
resistance (Mancia, 1993). The hypotension is markedly attenuated by surgical 
sympathectomy and can hence be largely ascribed to a reduction in sympathetic 
vasomotor tone as it has been highlighted for skeletal muscle vessels in human subjects 
(Somers et al., 1993); whereas the bradycardia is due mainly to an increase in vagal 
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nerve activity (Mancia, 1993). The decrease in arterial blood pressure occurs in cats and 
rats, although less consistent, but not in rabbits. In cats, heart rate decreases moderately, 
whereas stroke volume is practically unchanged. There is a significant decrease in heart 
rate in rats, but the decrease is less substantial significant in rabbits. See (Parmeggiani, 
2005) for a recent review. In humans there is a tonic decrease in arterial blood pressure 
(Coccagna et al., 1971), although it has varying intensity in different individuals 
(Mancia, 1993).  
At the level of the heart, an increase in baroreceptor reflex sensitivity has been 
frequently, although not constantly, reported in human subjects in NREM sleep 
(Conway et al., 1983). Moreover, in experimental model widely different in terms of 
species and developmental age, for example adult rat (Zoccoli et al., 2001; Silvani et 
al., 2003) or newborn lamb (Silvani et al., 2005), the role of the baroreceptor reflex in 
controlling heart rhythm has been demonstrated to be higher during NREM sleep than 
either during wakefulness or REM sleep. This distinctiveness of NREM sleep may in 
part underlie the greater stability in blood pressure observed during this state. 
The tonic changes in heart rate during NREM sleep may be ascribed either to 
baroreflex resetting or to the effects of central autonomic commands (Silvani & Lenzi, 
2005). The latter may be prominent, as heart rate still decreases from wakefulness to 
NREM sleep in rats after sinoaortic denervation (Sei et al., 1999). 
During NREM sleep, a near sinusoidal modulation of heart rate variation occurs due 
to a coupling with respiratory activity and cardiorespiratory centers in the brain and the 
result is what is termed normal respiratory sinus arrhythmia. During inspiration, heart 
rate accelerates briefly to accommodate increased venous return, resulting in increased 
cardiac output, whereas during expiration, a progressive slowing in rate ensues (Verrier 
et al., 2005). Respiratory sinus arrhythmia is prominent during NREM sleep, indicating 
a high degree of parasympathetic tone (Mancia, 1993). 
To summarize, NREM sleep with its autonomic stability provide a relatively salutary 
neurohumoral background during which heart has an opportunity of metabolic 
restoration. 
 
Different phenomena characterize REM sleep in both humans and animals. 
Endogenous brain activation, typical of this state, is accompanied by a prominent 
variability of heart rate and arterial blood pressure (Verrier et al., 2005). This variability 
is an important feature of REM sleep and it is generally associated with bursts of rapid 
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eye movements, myoclonic twitches and breathing irregularities (see Figure 2.3) 
(Verrier et al., 1996). Surges in cardiac-bound sympathetic and parasympathetic activity 
provoke accelerations and pauses in heart rhythm, in association with alterations in 
ponto-geniculo-occipital activity and  rhythm that are signs of phasic central nervous 
system activation in REM sleep (Verrier et al., 2005).  
 
 
 
Figure 2.3. Surges in heart rate and in blood pressure during REM sleep with phasic muscle twitch. 
EMG: electromyogram; EOG: electro-oculogram; ECG: electrocardiogram. Modified from (Verrier et al., 
1996). 
 
 
At cardiac level, heart rate fluctuates strikingly, with marked episodes of tachycardia 
and bradycardia (see Figure 2.4) (Verrier et al., 1996) and baroreceptor gain is reduced.  
However, such variability is not only the direct result of central changes in the 
regulation of the autonomic outflow; these changes also activate indirectly a number of 
feedback loops by affecting the peripherally controlled variables. So, the interaction 
between the central variability of visceral control during REM sleep and the central 
effects of activated reflexes are main factors in the generation of the instability of 
cardiovascular regulation in REM sleep. In this regard, circulation in different species is 
affected by similar central influences in REM sleep, although the eventual pattern of 
change in cardiovascular variables also depends on species-specific differences in the 
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operation of feedback loops and autoregulation. See (Parmeggiani, 2005) for a recent 
review. 
 
 
 
Figure 2.4. Minute-by-minute fluctuations in cardiovascular variables in REM sleep in human healthy 
subject. EEG: electroencephalogram; SBP: systolic blood pressure. Note that during REM sleep (minute 
242-273), two sustained bursts of eye movements (filled bars, top line) were associated with marked 
irregularities in SBP, respiratory frequency and heart rate. From (Verrier et al., 1996). 
 
 
The notion that central autonomic commands act on the heart and blood vessels 
during REM sleep has been recently quantified by assessing the role played by central 
commands and by the baroreflex in the control of heart rhythm during sleep (Zoccoli et 
al., 2001; Silvani et al., 2003; Silvani et al., 2005). In particular, parallel changes in 
heart period and blood pressure (e.g., a pattern of hypertension and cardiac slowing) 
indicate that heart rhythm control is mainly exerted by the baroreceptor reflex, whereas 
opposite changes in the two variables (e.g., a pattern of hypertension and tachycardia, 
like that observed during pressure surges in REM sleep) indicates that central 
autonomic commands prevail over the baroreflex in controlling heart rhythm (Zoccoli et 
al., 2001).  
In adult rats, central autonomic commands on the heart and blood vessels prevail in 
REM sleep as a whole over the control exerted by the baroreceptor reflex (Zoccoli et 
al., 2001; Silvani et al., 2003).  
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During REM sleep the activity of the brain increases and also cerebral blood flow 
increases. So, during REM sleep, there is flow-metabolism coupling. On the contrary, 
changes in other peripheral beds respond to sympatovagal balance and local activity 
changes that are sleep dependent and may conflict with the functional logic of the 
organs. Cerebral circulation during REM sleep shares the regulatory mechanism of 
other brain-activated states, but the disrupted integrated control of the remaining 
peripheral beds is unique to REM sleep (Franzini, 1992, 2005).  
To summarize autonomic regulation of the cardiovascular system during REM sleep 
can disrupt cardiorespiratory homeostasis.  
 
 
2.4.1 Phasic hypertensive events during REM sleep 
The control pattern of peripheral vascular beds in REM sleep is deeply affected by 
central autonomic commands and by reflexes other than the baroreflex (Baccelli et al., 
1974; Parmeggiani, 1980).  
Changes in regional sympathetic activity during REM sleep may take place in the 
absence of baroreflex resetting and of reflexes elicited by muscle atonia, and may thus 
represent the result of central autonomic commands issued by brainstem structure. See 
(Silvani & Lenzi, 2005) for a review.  
Likewise, central autonomic commands underlie the phasic hypertensive events (arterial 
pressure surges), which are superimposed upon the tonic level of arterial pressure in 
REM sleep. Several investigators have reported REM-induced increases in heart rate in 
experimental animals: cats (Mancia et al., 1971) (see Figure 2.5); rats (Sei & Morita, 
1996) (see Figure 2.6), where heart rate tends to rise during the pressure surges and 
increases significantly thereafter; mice (Campen et al., 2002) (see Figure 2.7), lambs 
(Fewell, 1993; Silvani et al., 2005) and also in human subjects (Coccagna et al., 1971) 
(see Figure 2.8). In these latter the arterial pressure may exceed the highest values 
recorded during wakefulness (Coccagna et al., 1971).  
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Figure 2.5. Original tracings from a REM sleep episode in cat, showing several phasic manifestations. 
Time (s); OM: ocular movements; EEG: electroencephalograms; EMG: electromyogram; BP: arterial 
blood pressure. Modified from (Mancia et al., 1971). 
 
 
 
 
 
Figure 2.6. Recordings of Arterial Pressure (AP), electro-oculogram (EOG) and electroencephalogram 
(EEG) signals during REM sleep in rat. Open arrows with dotted line indicate the trigger point for the 
summation of each signal (beginning point of eye movement burst). Modified from (Sei & Morita, 1996). 
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Figure 2.7. Representative tracings of arterial blood pressure (PSA) responses during NREM and REM 
sleep in a DBA/2J mouse. At the onset of REM sleep, the PSA of the DBA/2J mouse shows surges of 10 
mmHg or more above NREM levels during REM sleep. REM, rapid eye movement sleep; NREM, non-
REM sleep. Modified from (Campen et al., 2002). 
 
 
 
 
 
Figure 2.8. Histogram of sleep and trend of the maximal and minimal arterial pressure in a man. During 
REM sleep pressure values are indicated every 30 seconds (instead of every 60 seconds during NREM 
sleep) to show the phasic pressure variations. St. refers to sleep stage and W to waking state. Modified 
from (Coccagna et al., 1971). 
 
 
 
During arterial pressure surges, peripheral vascular resistance increases and also 
coronary vascular resistance (Fewell, 1993), despite of the greater cardiac metabolic 
demand during the hypertensive events. The increase in muscle vascular resistance 
(Mancia et al., 1971) is abolished by sympathectomy but not by limb deafferentation, 
proving that local reflexes are not necessary for its origin (Baccelli et al., 1974).  
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The baroreflex may play a role in shaping blood pressure surges in REM sleep, as 
suggested by the finding that muscle sympathetic nerve activity increases before the 
surges, but abruptly ceases during their course (Somers et al., 1993) (see Figure 2.9). 
 
 
 
 
Figure 2.9. Recording of Sympathetic-Nerve Activity (SNA) and Mean Blood Pressure (BP) in muscle 
blood vessel in human subject. There was a frequent association between REM twitches (momentary 
periods of restoration of muscle tone, denoted by T on the tracing) and abrupt inhibition of sympathetic-
nerve discharge and increased in blood pressure. Modified from (Somers et al., 1993). 
 
 
 
At cardiac level, a tachycardia occurs in lambs at the beginning of the arterial pressure 
surges, indicating that central autonomic commands prevail on the heart as well as on 
blood vessels at surge onset. Later, heart period and mean arterial pressure are both 
increased over baseline values, highlighting that the baroreflex effect on the heart 
prevails late in the course of the surges, in spite of enduring central control on blood 
vessel (Silvani et al., 2005) (see Figure 2.10). 
 
 
 
   30 
 
 
Figure 2.10. Beat-to-beat changes in Mean Arterial Pressure and Heart Period during phasic blood 
pressure surges in REM sleep in newborn lambs. Beat-to-beat values of heart Period and Mean Arterial 
Pressure were divided by their baseline values and averaged with the cardiac cycles corresponding with 
the onset of the Mean Arterial Pressure surges coinciding. Mean values ± SEM are shown. Heart Period 
started to decrease at the onset of the surge; an increase in Heart Period is evident later in the course of 
the Mean Arterial Pressure surge, consistent with baroreflex control. *p<0.05 for the difference between 
Heart Period (average value over the cardiac cycles identified by horizontal lines) and its baseline value. n 
= 7. From (Silvani et al., 2005). 
 
 
In dogs heart rate surges are accompanied by a rise in mean arterial pressure and are 
followed by a rate deceleration that is apparently baroreceptor mediated. Because the 
sequence is completely abolished by interruption of sympathetic neural input to the 
heart (Kirby & Verrier, 1989), the acceleration does not appear to be dependent on 
withdrawal of parasympathetic nerve activity (Dickerson et al., 1993).  
The rate accelerations are linked to central nervous system activation as reflected in a 
concomitant increase in incidence and frequency of hippocampal  waves, ponto 
geniculo-occipital (PGO) activity, and eye movements (Rowe et al., 1999) (see Figure 
2.11). The hippocampus is one of the important limbic structures, and shows a 
rhythmical sinusoidal EEG ( wave) during REM sleep, especially in rodents. This 
appearance of a  wave is indicative of the pronounced activity of the limbic system 
during REM sleep. In cats and rats, the appearance of theta waves is characteristic of 
arousal, orienting activity, alertness and REM sleep (Sei & Morita, 1996; Rowe et al., 
1999). 
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Figure 2.11. Representative polygraphic recording of a heart rate surge during REM sleep associated 
with eye movements, fast theta activity in the hippocampus, and a burst of pontogeniculooccipital (PGO) 
spikes. Before and after this heart rate surge, hippocampal field potentials, although exhibiting rhythmic 
activity in the theta range, were of variable amplitude and frequency. In contrast, hippocampal theta 
activity stabilized, and its frequency increased in association with the surge. No PGO spikes occurred 
during the 6 s preceding the surge, and single spikes dominated the control period after the surge. The 
channels recorded were electromyogram, electrooculogram (EOG), transcortical, hippocampal theta 
rhythm (CA1), electrocardiogram (ECG), and PGO waves of the lateral geniculate nucleus (LGN). 
During this surge, heart rate increased from 150 to 204 beats/min or 26.4%. From (Rowe et al., 1999). 
 
 
 
In rats, Sei and Morita (1996) reported an association between  activity, eye 
movements, and increased heart rate and blood pressure. They demonstrated a 
significant increase in theta frequency at 1 s before eye movement activity. However, 
they did not find a consistent correlation with increased mean arterial pressure or heart 
rate, which, when it occurred, was delayed by 7 s (see Figure 2.12). 
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Figure 2.12. Changes in eye movement (EM) number, theta frequency, mean arterial pressure (MAP) and 
heart rate (HR) in 1s bins. The onset of EM burst (time 0) was taken as a reference point, indicated by a 
dotted line. The relative changes in theta frequency, MAP and HR were calculated from the baseline 
values obtained from the 5s period indicated by a closed horizontal bar at bottom. *<0.05, one-way 
ANOVA with Bonferroni-Dunn test, compared with the baseline vaue. Modified from (Sei & Morita, 
1996).  
 
 
2.5 Respiratory function 
 
Sleep is a time when the respiratory tranquillity of resting wakefulness is replaced by 
conspicuous respiratory variability due to changes in both the drive to the ventilatory 
pump muscles and the upper airway opening muscles. Breathing during wakefulness is 
controlled by several factors, including voluntary and behavioural elements, chemical 
factors, and mechanical signals from the lung and chest wall. During sleep, there is loss 
of voluntary control and a decrease in the usual ventilatory response to both low oxygen 
and high carbon dioxide levels (Douglas, 2005).  
The transition from wakefulness to NREM sleep is characterized by the inactivation 
of the telencephalic control mechanism, typical of the wakefulness, and the release of 
the automatic control mechanism of the reticular formation of the brain stem. This 
transition (stages 1 and 2 of NREM sleep in humans) is characterized by breathing 
instability and the appearance of respiratory and circulatory periodic phenomena. 
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Regular breathing sets in with deep NREM sleep (stages 3 and 4 in humans), when 
breathing is driven by the automatic control mechanism. Ventilation during NREM is 
lower than during wakefulness, and the deeper the NREM sleep stages, the lower is the 
ventilation. Mean inspiratory flow is decreased, whereas there are no consistent changes 
in inspiratory duration and cycle duration: the result is a decrease in tidal volume 
according to the metabolic rate (Krieger, 2005; Parmeggiani, 2005). 
The phenomena of REM sleep point to a profound alteration in the activity of the 
automatic control mechanism of respiration. REM sleep is characterized by erratic, 
shallow breathing with irregularities both in amplitude and in frequency synchronous to 
REM bursts that are most probably of central origin and related to REM sleep processes 
(Krieger, 2005). The irregularity consists of sudden changes in both respiratory 
amplitude and frequency, at times interrupted by central apneas lasting 10 to 30 
seconds, and is different from the regular periodic breathing at sleep onset. In animals, 
this irregular pattern persists during hypoxia, hypercapnia, and metabolic alkalosis, as 
well as after vagotomy and chemodenervation. For these reasons, it has been suggested 
that the breathing pattern is not dependent on chemical regulation processes but is 
produced by activation of the behavioural respiratory control system by REM sleep 
processes (Krieger, 2005). The frequency of breathing increases, tidal volumes 
decrease, and minute ventilation decreases; furthermore in humans, metabolic rate 
increases in REM sleep, presumably because of a large increase in cerebral metabolism 
(Orem & Kubin, 2005).  
 
 
2.6 Sleep as autonomic stress test 
 
Sleep implies profound autonomic changes in the activity of the central nervous 
system, altering the neural integration of cardioventilatory control. Moreover, sleep 
limits the variability in local metabolic needs associated with behavioural engagement 
with the external environment. However, cardiovascular challenges modify the sleep 
process, which in turn may further modify the regulatory capacity (Silvani & Lenzi, 
2005). The mean level and fluctuations around the mean of cardiovascular variables 
depend on the sleep-wake state and are not of exclusive physiological interest. Rather, 
the features of cardiovascular regulation during sleep (Verrier et al., 1996) and their 
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transition to the regulatory pattern of morning awakening (George, 2000) may play a 
role in pathophysiology of myocardial infarction, stroke and sudden death. 
Whereas sleep is generally considered to be a relatively tranquil state dominated by 
the relative autonomic stability of NREM sleep, the onset of REM sleep is associated 
with marked perturbations in the interplay between the two divisions of the autonomic 
nervous system (Verrier, 2000). 
NREM sleep is generally salutary with respect to ventricular arrhythmogenesis: 
activation of the vagus nerve reduces heart rate, increases cardiac electrical stability and 
reduces cardiac metabolic activity (Verrier et al., 2005) Anyway, in case of severe 
coronary disease or acute myocardial infarction, hypotension during NREM sleep can 
lead to myocardial ischemia because of the inadequate coronary perfusion pressure and 
thereby provoke arrhythmias and myocardial infarction (Mancia, 1993).  
The abrupt increases in vagus nerve tone that can occur during periods of REM sleep 
can result in significant pauses in heart rhythm or bradyarrhythmias. Moreover, the 
increase in sympathetic nerve activity that occurs at the onset of REM sleep (Somers et 
al., 1993) provides a potent stimulus for ventricular tachyarrhythmias because of the 
arrhythmogenic influence of neurally released catecholamines. Experimentally-induced 
increases in sympathetic nerve activity can encourage cardiac vulnerability in the 
normal and ischemic heart. Thus, surges in sympathetic and parasympathetic nerve 
activity during REM sleep, which are well tolerated in normal individuals, may result in 
arrhythmias, myocardial ischemia and myocardial infarction in those with heart disease 
(Verrier et al., 2005).  
For all of these considerations, sleep may constitute an “autonomic stress test” for the 
cardiovascular system, and could prove helpful in identifying individuals at risk for 
sudden cardiac death, because a pathological pattern of cardiovascular regulation may 
become evident earlier during sleep than in wakefulness (Verrier et al., 1996). 
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3. Hypertension 
 
 
Blood pressure in human populations is distributed normally and the cutoff point for 
high blood pressure is arbitrary. The diagnosis of hypertension in adult is made when 
average of two or more diastolic blood pressure measurements on at least two 
subsequent visits is 90 mmHg or more or when the average of multiple systolic blood 
pressure readings on two or more subsequent visits is consistently greater than 140 
mmHg. The current classification results from two international guidelines, developed 
by the Sixth Joint National Committee on Detection, Evaluation and Treatment of High 
Blood Pressure of U.S.A. (JNC VI) and the World Health Organization-International 
Society of Hypertension (WHO-ISH), and indicates several levels of risk on the basis of 
systolic and diastolic pressure values (see Table 3.1) (Oparil, 2000). 
 
 BLOOD PRESSURE (mmHg) 
 Systolic Diastolic 
Optimal <120 <80 
Normal <130 <85 
High-Normal 130-139 85-89 
Hypertension 
Stage 1 
Stage 2 
Stage 3 
 
140-159 
160-179 
180 
 
90-99 
100-109 
110 
 
Table 3.1. Classification of blood pressure for adults. From (Oparil, 2000). 
 
 
3.1 Prevalence 
 
The prevalence of hypertension depends on both racial composition of the population 
studied and the criteria used to define the condition.  
The prevalence of blood pressure increases with age: it is a common health problem in 
the geriatric population, afflicting approximately 65% of the population in the 65-74 
year old group. Blacks have a higher prevalence of hypertension than whites (38% 
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versus 29%) and men have a higher overall prevalence of hypertension than women 
(33% than 27%), up to approximately age 50; after that age, hypertension is more 
common in women (Oparil, 2000); this increase is presumably related to the hormonal 
changes of menopause (Williams, 1995).  
In European countries systemic hypertension, with its burden of cardiac, vascular, and 
renal complications is a major health problem and its prevalence is 44% (Wolf-Maier et 
al., 2003). 
 
 
3.2 Essential Hypertension 
 
Individuals in whom generalized or functional abnormalities may be the cause of 
hypertension are defined as having primary, essential, or idiophatic hypertension. More 
than 95% of all cases of hypertension are of unknown cause. The main difficulty in 
uncovering the mechanism responsible for the hypertension in these patients is 
attributable to the variety of systems that are involved in the regulation of arterial 
pressure- peripheral and/or central adrenergic, renal, hormonal, and vascular- and to the 
complexity of the interrelations of these systems.  
Primary hypertension tends to cluster in families and represents a collection of 
genetically based diseases and/or syndromes with a number of underlying inherited 
biochemical and pathophysiologic factors. High blood pressure, in most cases, results 
from a complex interaction of genetic, environmental and demographic factors and the 
development of the disease is slow and gradual. By the time that blood pressure become 
elevated, the initiating factors may no longer be apparent because they may have been 
‘normalized’ by multiple compensatory interactions (Oparil, 2000).  
Individuals in whom a specific structural organ or gene defect is responsible for 
hypertension are defined as having a secondary form of hypertension. Systemic 
hypertension of known etiology accounts for fewer than 5% of all cases of systemic 
hypertension. Common causes of secondary hypertension are renal diseases, endocrine 
diseases, neurologic disorders and also some drugs and chemicals. Importance of 
identifying patients with secondary hypertension is that they can sometimes be cured by 
surgery or by specific medical treatment (Williams, 1995; Oparil, 2000). 
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3.3 Mechanisms of primary hypertension 
 
Since persistent hypertension can develop only in response to an increase in cardiac 
output or a rise in peripheral resistance, defects may be present in one or more of the 
multiple factors that affects these two variables. The interplay of various derangements 
in factors affecting cardiac output and peripheral resistance may precipitate the disease, 
and these abnormalities may differ in both type and degree in different patients (see 
Figure 3.1) (Kaplan, 2001). 
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insulinemia
Fluid
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BLOOD PRESSURE = CARDIAC OUTPUT X PERIPHERAL RESISTANCE
Hypertension = Increased CO        and/or       Increased PR
Autoregulation
 
 
Figure 3.1. Some of the factors involved in the control of blood pressure. Modified from (Kaplan, 2001). 
 
 
Genetic predisposition 
Genetic alterations may initiate the cascade to permanent hypertension. In studies of 
twin and family members in which the degree of familial aggregation of blood pressure 
levels is compared with the closeness of genetic sharing, the genetic contributions have 
been estimated to range from 30 to 60 percent (Harrap, 1994). 
Three rare forms of hypertension have been found to be caused by a monogenic 
abnormality (Luft, 1998); in addition, polymorphism of genes involving the rennin-
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angiotensin system, aldosterone synthesis, and adrenergic receptors has been noted to be 
more common in hypertensive than normotensive patients (Kaplan, 2001).  
 
Renal retention of excess dietary sodium 
A lot of evidences support a role for sodium in the genesis of hypertension: some of 
that excess sodium must be retained by the kidneys. More than enough ways are 
available to incite renal retention of even a very small bit of the excess sodium typically 
ingested that could eventually expand body fluid volume. Variations in sensitivity to 
sodium may explain why only some people respond to excess sodium and others do not. 
The retention could arise in a number of ways, comprising (Kaplan, 2001): 
1. a decrease in filtration surface by a congenital or acquired deficiency in nephron 
number or function; 
2. a regulation of the normal pressure-natriuresis relationship wherein a rise in 
pressure invokes an immediate increase in renal sodium excretion, thereby 
shrinking fluid volume and returning the pressure to normal; 
3. nephron heterogeneity: a subpopulation of nephrons that is ischemic either from 
afferent arteriolar vasoconstriction or from an intrinsic narrowing of the lumen. 
Rennin secretion from this subgroup of nephrons is tonically elevated and this 
increased renin secretion interferes with the compensatory capacity of 
intermingled normal nephrons to adaptively excrete sodium and, consequently, 
perturbs overall blood pressure homeostasis; 
4. an acquired inhibitor of the sodium pump or other abnormalities in sodium 
transport; 
5. defective responsiveness to atrial natriuretic hormone. 
 
Vascular hypertrophy 
Multiple vasoactive substances act as growth factors for vascular hypertrophy. These 
pressor-growth promoters may result in both vascular contraction and hypertrophy 
simultaneously, but perpetuation of hypertension involves hypertrophy (Kaplan, 2001).  
 
Sympathetic nervous hyperactivity 
In primary human hypertension, measurement of regional sympathetic activity using 
electrophysiologic (sympathetic nerve recording) and neurochemical (measurement of 
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norepinephrine spillover) techniques has demonstrated activation of the sympathetic 
nervous outflows to the heart, kidneys, and skeletal muscle vasculature, particularly in 
younger patients. This sympathetic activation contributes to blood pressure elevation, 
and to the development of atherosclerosis, cardiovascular hypertrophy, and cardiac 
arrhythmias. The specific causes of the increased sympathetic activity in primary 
hypertension remain largely unknown, although genetic influences are evident and 
behavioural and lifestyle factors appear to be involved (Esler, 2000).  
The majority of evidence currently favours a pivotal role for the autonomic nervous 
system in the etiology of primary hypertension. A variety of confirmations support the 
concept of sympathetic hyperactivity and parasympathetic underactivity as central in the 
etiology of not only early and borderline hypertension, but also in the maintenance of 
sustained essential hypertension (see Figure 3.2) (Brook & Julius, 2000). 
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Figure 3.2. Autonomic imbalance. Modified from (Brook & Julius, 2000). 
 
 
Primary hypertension conveys an increased risk of cardiovascular morbidity and 
mortality. The common finding of an autonomic imbalance in these patients contributes 
to the etiology of hypertension itself, but also to the cardiac risk and resulting adverse 
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consequences. A high sympathetic tone in particular is responsible for many of the 
metabolic, hemodynamic, trophic, and rheologic abnormalities that cluster in patients 
with high blood pressure (Brook & Julius, 2000).  
Both sympathetic overactivity and parasympathetic underactivity contribute to the 
state of relative tachycardia in hypertension. Elevated plasma catecholamines and 
intraneural recordings also support the etiology to be neurogenic. High heart rate can 
increase morbidity and mortality by several mechanisms. Decreased parasympathetic 
tone, along with an activated sympathetic tone, is conducive to cardiac arrhythmias in 
both human and animal models. The relationship between elevated sudden death risk 
and high heart rate is likely explained by the fact that tachycardia leads to increased 
myocardial tissue oxygen demand. This often occurs in conjunction with left ventricular 
hypertrophy in hypertension, further increasing cardiac oxygen needs. In the setting of 
conditions common to hypertension (an elevated cardiac afterload, coronary 
atherosclerosis, endothelial dysfunction, reduced coronary vasodilatory reserve), high 
oxygen demand drastically predisposes to cardiac ischemia. Finally, a high heart rate 
has experimentally been shown to directly cause coronary atherosclerosis in animal 
models. The reverse is also true. Reducing heart rate 30% by ablating the sinoaortic 
node lowered the number and severity of coronary lesions by 50% in a high-
cholesterol–fed animal model (Beere et al., 1984). Higher coronary artery shear forces 
induced by tachycardia, particularly at artery branches, are likely responsible for this 
increased rate of atherosclerotic lesion formation. These findings suggest that the 
common condition of a high heart rate in patients with high blood pressure is not a 
benign condition. The autonomic imbalance in these patients causes this relative 
tachycardia. Therefore, methods to reduce heart rate by restoring normal autonomic 
nervous system tone should prove to be protective against cardiovascular consequences 
(Brook & Julius, 2000). 
 
Baroreceptor reflex 
As regard the baroreflex sensibility, it has been demonstrated that in primary 
hypertension, both in human subjects (Lucini et al., 1994) and in animal models 
(Oosting et al., 1997a; Nagai et al., 2003), the gain of cardiac effector is reduced. The 
baroreceptor reflex plays no role in long-term regulation of arterial pressure, because 
baroreceptors were thought to reset in 1 or 2 days toward whatever pressure level they 
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are exposed. However, very recent studies suggested that baroreceptors may not 
completely reset, at least not with regard to renal sympathetic nerve activity, and thus 
that baroreceptors may indeed be able to contribute to long-term mean arterial pressure 
(Persson, 2005). 
 
Renin-Angiotensin system 
Both as a direct pressor and as a growth promoter, the renin-angiotensin mechanism 
may also be involved in the pathogenesis of hypertension. Renin is an enzyme secreted 
by the juxtaglomerular cell of the kidney and linked with aldosterone in a negative 
feedback loop. A variety of factors can modify its rate of secretion, in particular changes 
in dietary sodium intake. The end product of the action of renin on its substrate is the 
generation of the peptide angiotensin II. The response of target tissues to this peptide is 
only determined by the prior dietary electrolyte intake. The range of plasma renin 
activities observed in hypertensive subjects is broader than in normotensive individuals. 
So that, some hypertensive patients have been defined as having low-renin and others as 
having high-renin essential hypertension. 
• Low-renin primary hypertension. About 20% of patients who by all other 
criteria have primary hypertension have suppressed plasma renin activity and 
expanded extracellular fluid volumes. Some studies have suggested that the 
adrenal cortex of some of these patients has an increased sensitivity to 
angiotensin II as the underlying mechanism. On a diet with normal or high 
sodium content, aldosterone production will not be suppressed normally, 
leading to a mild degree of hyperaldosteronism with its resulting increased 
sodium retention, volume expansion, and increase in blood pressure. 
• Non-modulating primary hypertension. About 25-30% of the hypertensive 
population has an adrenal defect opposite to that observed in low-renin 
patients, a reduced adrenal response to sodium restriction. In these individuals, 
sodium intake does not modulate either adrenal or renal vascular responses to 
angiotensin II. Hypertensives in this group have been termed non-modulators 
because of the absence of the sodium-mediated modulation of target tissue 
responses to angiotensin II; they have plasma renin activity levels that are 
normal to high if measured when the patient is on a low-salt diet, and have 
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hypertension that is salt sensitive because of a defect in the kidney’s ability to 
excrete sodium appropriately.  
• High-renin primary hypertension. Approximately 15% of patients with 
primary hypertension have plasma renin activity levels above the normal 
range. Plasma renin probably plays an important role in the pathogenesis of 
the elevated arterial pressure in these patients. Elevated renin levels and blood 
pressure may both be secondary to an increase in adrenergic system activity. It 
seems that, in patients with angiotensin-dependent high-renin hypertension 
whose arterial pressures are lowered by an angiotensin II antagonist, the 
mechanism responsible for the increase in renin and, therefore, for the 
hypertension is the non-modulating defect (Williams, 1995).  
 
Obesity 
Hypertension is more common among obese individuals and adds to their increased 
risk for ischemic heart disease. Even small amounts of weight gain are associated with a 
marked increase in the incidence of hypertension and coronary mortality (Kaplan, 
2001). 
 
Sleep apnea 
One of the contributors to the hypertension in obese persons is sleep apnea. Snoring 
and sleep apnea are often associated with hypertension, which may in turn be induced 
by increased sympathetic activity and endothelin release in response to hypoxemia 
during apnea (Kaplan, 2001). 
 
Other conditions  
A number of environmental factors have been implicated in the development of 
hypertension, including salt intake, alcohol intake, physical inactivity, smoking, 
haematological findings, hyperuricemia, insulin resistance, endothelial cell dysfunction, 
family size, occupation, crowding (Williams, 1995; Kaplan, 2001). 
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3.4 Effects of hypertension  
 
If untreated about 50% of hypertensive patients die of coronary heart disease or 
congestive failure, about 33% percent of stroke, and 10-15% of renal failure (Kaplan, 
2001). 
To what concern cardiac involvement, hypertension places increased tension on the 
left ventricular myocardium that is manifested as stiffness and hypertrophy, which 
accelerates the development of atherosclerosis within the coronary vessels. Combination 
of increased demand and lessened supply increases the likelihood of myocardial 
ischemia and thereby leads to a higher incidence of myocardial infarction, sudden death, 
arrhythmias, and congestive failure in hypertensives. 
Renal dysfunction too unperceivable to be recognized may be responsible for the 
development of most cases of primary hypertension. Increased renal retention of salt 
and water may be a mechanism initiating primary hypertension, but retention is so small 
that it escapes detection. As hypertension-induced nephrosclerosis proceeds, the plasma 
creatinine level begins to rise and eventually, renal insufficiency with uremia may 
develop, thus making hypertension a leading cause of end-stage renal disease. 
To what concern cerebral involvement, hypertension may accelerate cognitive decline 
with age. Systolic hypertension, in particular, is a major risk factor for initial and 
recurrent stroke and for transient ischemic attacks caused by extracranial atherosclerosis 
(Kaplan, 2001). 
 
 
3.5 Treatment of hypertension 
 
The goal of antihypertensive therapy is to reduce overall cardiovascular risk and thus 
cardiovascular morbidity and mortality. 
Non drug therapeutic intervention is probably indicated in all patients with sustained 
hypertension and probably in most with labile hypertension. The general measures 
employed include: relief of stress, dietary management, regular aerobic exercise, weight 
reduction and control of other risk factors contributing to the development of 
atherosclerosis. 
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Monotherapy with most antihypertensive drugs effectively controls blood pressure in 
fewer than 50% of patients. In general there are six classes of drugs: diuretics, 
antiadrenergic agents, vasodilatators, calcium entry blockers, angiotensin-converting 
enzyme (ACE) inhibitors and angiotensin receptor antagonists (Williams, 1995; Oparil, 
2000). 
The drug used in this work was Enalapril (Adams et al., 1990), an angiotensin 
converting enzyme inhibitor. Enalapril (see Figure 3.3) is a prodrug that is converted by 
deesterification to a converting enzyme inhibitor, enalaprilat. Enalapril is converted to 
the active metabolite by hydrolysis, primarily in the liver. Peak concentrations of 
enalaprilat occur 3–4 hours after dosing with Enalapril, and the half-life of enalaprilat is 
about 11 hours (Benowitz, 2001). 
 
 
Figure 3.3. Chemical structure of Enalapril (Benowitz, 2001). 
 
 
Enalaprilat inhibits the enzyme converting angiotensin I into angiotensin II, the 
angiotensin converting enzyme (ACE). This agent is useful because it not only inhibits 
the generation of a potent vasoconstrictor (angiotensin II) but also may retard the 
degradation of a potent vasodilator (bradykinin), alter prostaglandin production and can 
modify the activity of the adrenergic nervous system. It is especially useful in renal or 
renovascular hypertension (Williams, 1995).  
Angiotensin II inhibitor lowers blood pressure principally by decreasing peripheral 
vascular resistance. Cardiac output and heart rate are not significantly changed. Unlike 
direct vasodilator, this agent does not result in reflex sympathetic activation and can be 
used safely in persons with ischemic heart disease. The absence of reflex tachycardia 
may be due to downward resetting of the baroreceptors or to enhanced parasympathetic 
activity. Although converting enzyme inhibitor is most effective in conditions 
associated with high plasma renin activity, there is no good correlation among subjects 
between plasma renin activity and antihypertensive response, and renin profiling is 
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unnecessary. ACE inhibitors have a particularly useful role in treating patients with 
diabetic nephropathy because they diminish proteinuria and stabilize renal function 
(even in the absence of lowering of blood pressure).  
Severe hypotension can occur after initial doses of any ACE inhibitor in patients who 
are hypovolemic due to diuretics, salt restriction, or gastrointestinal fluid loss. Other 
adverse effects common to all ACE inhibitors include acute renal failure, hyperkalemia, 
dry cough sometimes accompanied by wheezing, and angioedema. Hyperkalemia is 
more likely to occur in patients with renal insufficiency or diabetes. Bradykinin and 
substance P seem to be responsible for the cough and angioedema seen with ACE 
inhibition (Benowitz, 2001). 
 
 
3.6 Animal model of hypertension: the Spontaneously 
Hypertensive Rat 
 
Hypertension is a multifactorial, polygenic disease that involves complex interactions 
between genetically determined homeostatic control mechanisms and environmental 
factors, and its exploration thus requires availability of experimentally manipulable 
animal models. The ideal animal model for hypertension research should have human-
like cardiovascular anatomy, hemodynamics, and physiology and develop human 
disease characteristics and complications in accelerated fashion. Inevitably, no species 
can consistently answer all of these needs, and experimental design and other 
constraints often dictate the choice of animal models for specific research applications.  
In human primary hypertension, multiple genes contribute to the individual disease 
phenotype; as a result, no single genetic defect can explain development of primary 
hypertension. Growth of experimental models of hypertension allowed dissection and 
isolation of various factors associated with regulation of blood pressure, inheritance of 
hypertensive traits, and cellular responses to injury (Lerman et al., 2005). 
The major part of the experimental hypertension research has been carried out in 
rodents, namely, in the rat (Folkow, 1990), which is very convenient for the study of 
cardiovascular physiology and which has a particular potential for exploration of 
polygenic hypertension. In the rat, the wide spectrum of experimental hypertension 
models so far available differs in the contribution of genetic and environmental factors 
   46 
to the elevation of blood pressure. In general, development of homozygous hypertensive 
rat strains is achieved by selective breeding of animals displaying the desired phenotype 
over several generations (Lerman et al., 2005).  
One of the first strains of inherited hypertension was the genetically hypertensive rat 
developed from the New Zealand strain (Smirk & Hall, 1958). Other important 
hypertensive rat strains include the salt-sensitive Dahl and the Sabra model, which 
exhibits gender-specific quantitative trait loci for salt susceptibility on chromosome 1 
SS1a and SS1b in men and SS1b in women (Yagil et al., 2003). Other important models 
include the Lyon genetic hypertensive rat, a model of low-renin hypertension that shows 
hypersensitivity of preglomerular vessels to AngII (Sassard et al., 2003), and Milan 
SHR, which has a mutation in the gene coding for adducin, a skeletal protein involved 
in transepithelial sodium transport (Cusi et al., 1993). Many of these models indeed 
mimic the human form of low-renin hypertension (Lerman et al., 2005). 
In most phenotype-driven models, hypertension is associated with cardiac hypertrophy, 
endothelial dysfunction, and renal functional impairment (proteinuria, decreased 
creatinine clearance), but cardiac insufficiency and end-stage renal disease are not 
consistently observed. The outcomes seem to depend on the underlying origin, genetic 
background, and possibly species differences, as well as on the degree of hypertension 
(Lerman et al., 2005).  
The Spontaneously Hypertensive Rats (SHR) strain, the current paradigm for essential 
hypertension research, was developed in a breeding program based solely on selection 
by elevated blood pressure in the Wistar Kyoto rats (WKY) by Okamoto in 1964 
(Okamoto & Aoki, 1963). The WKY strain was established as a normotensive control 
strain for the SHR by inbreeding of the normotensive Wistar colony (from which the 
SHR originally emerged) by brother/sister mating (Friese et al., 2005). In particular, a 
48% allelic difference exists between the SHR strain and the WKY strain (Cowley et 
al., 2004). 
In addition to elevated blood pressure, the SHR exhibits many of the co-morbidities 
observed in human hypertension, such as insulin resistance, hypertriglyceridemia, and 
abdominal obesity (Friese et al., 2005). The SHR model spontaneously develops 
hypertension without need of any dietary or surgical manipulation and has become the 
most used animal model for research on polygenic hypertension. 
The worldwide availability of SHR has made possible not only to identify numerous 
cardiovascular abnormalities in this model, but also to estimate the degree of their 
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genetic determination, to study their ontogenetic aspects in detail and to evaluate their 
role in the pathogenesis of hypertension by means of various interventions (Zicha & 
Kunes, 1999). The SHR is not a strictly inbred strain and gives way to a wide variety of 
genes to cosegregate and may mimic a subtype of human primary hypertension that is 
inherited in a Mendelian fashion. The genetic mechanisms of hypertension in SHR have 
been attributed to both neural and vascular alterations (Lerman et al., 2005).  
As we can see in Figure 3.4, the blood pressure of SHR newborns was usually found 
to be significantly higher compared with that of WKY rats, characteristic acceleration of 
the blood pressure rise in SHR mainly occurs between the 3rd and 10th week of age 
when their blood pressure rapidly increases by ~ 30% above that of WKY rats. The 
blood pressure of WKY rats reaches adult levels by ~ 10 wk of age, but in SHR, it 
continues to rise at least until the age of 20 wk. There is no doubt that high blood 
pressure in hypertensive humans or animals is caused by an elevation of systemic 
resistance, the greater part of which is partially caused by the decrease of arteriolar 
lumen diameter due to media thickening or remodelling (Zicha & Kunes, 1999).  
 
 
 
Figure 3.4. Ontogeny of mean arterial blood pressure (MAP), cardiac output (CO), and total peripheral 
resistance (TPR) in spontaneously hypertensive rats (SHR) expressed as percentage of Wistar-Kyoto 
(WKY) control rats. Data adapted from (Zicha & Kunes, 1999). 
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In SHR, the clinical course of the hypertensive disease and the pathological findings, 
such as cardiac hypertrophy and arterial sclerosis, are similar to those observed in 
human patients. Indeed, as in human primary hypertension, the blood pressure is 
relatively normal in the young SHR, increases with age and terminates in heart failure, 
cerebrovascular accidents, renal insufficiency or in the malignant phase of the disease 
(Grollman, 1972). 
 
 
3.7 Hypertension and sleep 
 
Epidemiologic evidence has provided important links between sleep-related disorders 
and primary hypertension. Since sleep ultimately consumes approximately one third of 
a human life, studying the relationship between sleep disorders and cardiovascular 
diseases has gained popularity. In particular, systemic hypertension is associated with 
sleep-related autonomic deregulation (Heald et al., 1989; Kuo et al., 2004a) and 
breathing disorders (Carley et al., 2000) as well as with alterations in the sleep pattern 
(Kuo et al., 2004b).  
Up to 60% of patients with sleep apnea may have hypertension, but the mechanisms 
underlying the link between obstructive sleep apnea and hypertension are not 
completely established. Most studies show that treatment of sleep disordered breathing 
modestly improves nocturnal and diurnal blood pressure in patients with sleep apnea 
(Silverberg et al., 2002) and often confers improvements in subjective symptoms, 
especially daytime somnolence.  
Further evidences concerning the interaction between blood pressure and sleep come 
from non-dipper population studies. Normally during NREM sleep, systolic blood 
pressure is 10% to 20% lower than that during quiet wakefulness (Mancia et al., 1971). 
Blood pressure is higher during REM sleep than during NREM sleep, but does not reach 
awake levels. Individuals with this 24-h blood pressure profile have been labelled 
‘dippers’. This dipper pattern has been observed in most patients with essential 
hypertension. The flattened 24-h blood pressure pattern in ‘non-dippers’ occurs in a 
minority of patients with essential hypertension. It is not clear whether these individuals 
experience a reduction in the nocturnal decline in blood pressure or failure in 
appropriate blood pressure rise during the daytime (George, 2000). Dipping has been 
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postulated to be a restorative physiologic process (Rosansky et al., 1996), with a 
potential impact also on the quality of sleep. A recent study reported that in a population 
of healthy subjects deeper sleep was associated with more blood pressure dipping; 
conversely, the same study could also suggest that lighter and more disturbed sleep may 
be associated with less dipping (Loredo et al., 2004). 
Whatever the specific role of sympathetic activity in the pathogenesis of hypertension, 
it appears to be involved in the increased cardiovascular morbidity and mortality that 
affect hypertensive patients during the early morning hours. Increased -sympathetic 
activity occurs in the early morning in association with the preawakening increase in 
REM sleep and the assumption of upright posture after overnight recumbency (Panza et 
al., 1991). As a consequence of the increased sympathetic activity, blood pressure rises 
abruptly and markedly. This rise must be at least partly responsible for the increase in 
cardiovascular catastrophes in the early morning hours (Muller, 1999). 
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4. Methods 
 
 
Experiments were performed on 14 male Spontaneously Hypertensive Rats (SHR) and 
7 male Wistar-Kyoto rats (WKY) (Charles River Italia, Calco, Italy). Animals were 
housed individually and were kept on a light/dark cycle of 12 hour period with light on 
at 9 a.m., ambient temperature at 23 ± 1 °C and free access to food (standard rodent 
diet, 4RF21, Mucedola, Milano, Italy) and tap water.  
The study protocol was approved by the Bologna University ethical committee on 
animal experimentation.  
 
 
4.1 Drug therapy of Spontaneously Hypertensive Rats 
 
A group of 7 SHR, hereafter termed the SHRace group, was treated with Enalapril 
maleate from the age of 4 weeks to the end of the experiment. Enalapril (Enalapril 
maleate salt, Sigma-Aldrich, Milano, Italy), an ACE-inhibitor, was dissolved in tap 
water (25-30 mg/Kg/day) (Adams et al., 1990). The water consumption of the SHRace 
rats was monitored and the concentration of Enalapril was adjusted to maintain the 
ingested dose per unit body weight approximately constant across days.  
 
 
4.2 Surgical procedures 
 
At the age of 9 weeks, rats were implanted under general anaesthesia (1.2% halothane, 
30% O2, balance N2O) and sterile conditions with electrodes for 
electroencephalographic (EEG) and electromyographic (EMG) recordings, a catheter in 
the abdominal aorta, and a thermistor in the nasal cavity to measure the breathing rate. 
Animals were placed on a heating pad throughout the experiment, and the rectal 
temperature was maintained at 37 ± 0.5°C. 
Ketoprofen (Aventis, 1 mg / 100 g body weight) was administered subcutaneously for 
postoperative analgesia (Roughan & Flecknell, 2001). Benzilpenicillin benzatinic 
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(Fournier, 15000 IU / 100g body weight) and streptomycin sulphate (Bristol-Myers 
Squibb, 20000 IU / 100g body weight) were administered subcutaneously for antibiotic 
prophylaxis at the end of the surgery.  
 
Catheter 
A non-occlusive saline-filled catheter (0.30 mm in inner diameter, 0.64 mm in outer 
diameter) made of silicone rubber (Silastic™, Medical grade) was inserted in the 
abdominal aorta via the left femoral artery for blood pressure monitoring and blood 
sampling. The silicone rubber is suitable for this application because inert and bio-
compatible. In addition, it can be sterilized in autoclave while remaining extremely 
flexible and hence minimally traumatic for blood vessels. One week before the surgery, 
the catheter was heparinized (Waynforth & Flecknell, 1992). The purpose of this 
procedure was to let heparin molecules stick to catheter wall, so as to avoid the 
deposition of the platelet-fibrin complex (thrombus) in the tip of the catheter after its 
implantation. The catheter was soaked for 30 minutes in 5% 
tridodecylmethylammonium chloride (TDMAC, Sigma-Aldrich, Milano, Italy) in 
ethanol 95%. It was then air dried and washed five times with distilled water. Following 
this, it was filled with heparin (Eparina Vister, 5000 U.I. /ml, Pfizer) solution and 
incubated for 30 minutes. Finally, the catheter was again allowed to air dry, washed five 
times with distilled water, and sterilized in a Composite IMO autoclave. During surgery, 
the catheter was tunnelled subcutaneously from an incision in the neck to an incision in 
the inguinal left region. The left femoral artery was then isolated and catheterized.  
 
Electrodes 
Rats were mounted in a stereotaxic instrument to immobilize the skull. Three 
miniature stainless steel screws were soldered to copper insulated wire and implanted 
into the skull for bipolar EEG recordings: one electrode 1.0 mm anterior and 2.0 mm 
lateral to bregma, two electrodes bilaterally to the lambda (0.0 mm anterior and 2.0 mm 
lateral). Besides, two electrodes for unipolar EEG recordings were implanted for record 
the K Complex (1.0 mm posterior and 2.0 mm lateral to bregma, and 5.0 mm posterior 
and 0.0 mm lateral to lambda) (Marini et al., 2004) (see Figure 4.1). We used two EEG 
derivations: the first is the bipolar fronto-parietal derivation for the traditional scoring of 
the wake-sleep cycle in rodents; the second one is a monopolar derivation in order to 
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improve the amount of information for sleep scoring. In fact, one electrode (the active 
one) was placed just behind the bregma on the parietal bone, while the second electrode 
(the reference) was implanted in the midline above the cerebellum.  
Two Teflon-coated stranded wire silver (Coonerwire, Chatsworth, CA, USA) 
electrodes were also implanted bilaterally in the dorsal nuchal muscles to record EMG 
activity.  
 
 
 
Figure 4.1. Position of electrodes on rat head. 
 
Thermistor  
A thermistor was inserted into left nasal cavity through the skull (2.0 mm anterior to 
the suture between the left frontal bone and the left nasal bone and 1.0 mm lateral to the 
suture between the nasal bones) to measure temperature variations resulting from 
ventilation (see Figure 4.1). There is a large temperature difference between air coming 
out of the respiratory system (body temperature) and air going into the respiratory 
system: during nasal expiration the temperature will increase; during nasal inspiration 
the temperature will decrease.  
A thermistor is a thermally sensitive resistor that is supplied with a constant but low 
current. The use of a low current reduces the tendency of the thermistor to heat itself. It 
is desirable that small temperature changes produce large resistance changes. Expired 
airflow heats the sensor, increasing its resistance, and inspiratory airflow cools the 
sensor to ambient temperature, resulting in a relative decrease in the resistance that can 
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then be recorded. A thermistor ceases being an airflow sensor if it touches the skin, 
because it will remain at body temperature (Hirshkowitz & Kryger, 2005).  
 
The electrodes and the thermistor were soldered to a connector and fixed to the skull 
together with the distal end of catheter by acrylic dental cement. 
The surgery lasted approximately three hours. After the surgery, rats were housed 
individually in cages for recovery. Each animal was allowed 6 days for postoperative 
recovery, during which the catheter was flushed with heparinized saline solution (50 
U/ml, 150 µl) every day, to avoid occlusion because of clot formation. By the end of the 
recovery period, rats did not show abnormalities in gaiting and feeding and regained 
weight normally. 
 
 
4.3 Experimental procedures 
 
After recovery, each animal was placed for recordings in a thermoregulated 
(minimum temperature: 22±1°C; maximum temperature: 24±1°C), sound-attenuated 
box. The catheter was connected via an external polyethylene tube to a transducer (P23, 
Statham, Hato Rey, Puerto Rico). Food and water were available ad libitum. The signals 
were continuously recorded for 4 consecutive days from 10.00 a.m. to 6.00 p.m., the 
light-period that represents the restorative period in rodents, with the animals 
undisturbed and freely moving in their own cages.  
On the fifth recording day, the arterial catheter was connected to a thinner 
polyethylene tube (20 l in volume) for blood withdrawal. The small calibre of this 
polyethylene catheter allowed a minimal dead space, but at the same time caused an 
elevate resistance, making it unsuited to record the blood pressure. For this reason, the 
arterial pressure was not recorded the fifth day. Blood was withdrawn to flush the dead 
space of the catheter before each blood sampling, and subsequently re-infused to 
minimize the animal’s blood loss. 
Blood samples (150 l) were obtained in undisturbed rats and immediately analyzed by 
a blood-gas analyzer (Gem 3000, Instrumentation Laboratory, Milano, Italy) to measure 
pH, partial pressures of oxygen and carbon dioxyde, hematocrit and electrolyte 
concentrations in the arterial blood. 
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Once the blood sampling was completed, the animal was sacrificed with an overdose 
of anaesthetic and the autopsy was executed to check for inflammatory processes, 
particularly in the abdominal aorta and at the cranial level.  
 
 
4.4 Data acquisition and storage 
 
Electrophysiological signals were amplified and filtered with the signal conditioner. 
The bipolar EEG and unipolar EEG signals were band-pass filtered from 0.3 to 60 Hz; 
the EMG signal was band-pass filtered from 100 to 1000 Hz; the ventilatory activity 
signal was band-pass filtered from 0.3 to 15 Hz. The arterial pressure signal was low-
pass filtered at 100 Hz. The gain of the amplification of EEG and EMG signals was 
adjusted by the operator for each rat to compensate for variable resistance of the 
electrodes. 
Dedicated software developed in C was used to visualize and acquire data. The 
bioelectric signals were relayed to a 12-bit analog-digital converter connected to a 
personal computer. The sample rate for EEG, EMG and ventilatory activity signals were 
128 Hz, while the arterial pressure signal was sampled at 1024 Hz. 
All signals were visualized on-line so that the operator could make a preliminary 
discrimination of the sleep stages; this operation was also facilitated by a Fast Fourier 
Transform (FFT) analysis performed on-line that visualised the power spectrum of the 
EEG signal ( band: 0.5-4.5Hz;  band: 6-9Hz;  band: 12-16Hz). 
 
 
4.5 Data analysis  
 
Polygraphic signals were visualized offline by means of software written ad hoc in 
MATLAB language (The MathWorks, Inc., U.S.A.). 
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4.5.1 Visual scoring 
The sleep-wake state was scored visually according to electroencephalographic 
criteria, muscle tonus and twitches, and behavioural criteria; the analysis was performed 
with a temporal resolution of 2 seconds because of the polyphasic wake-sleep cycle of 
the rodents, which consists of several short-lasting stages alternating rapidly. 
REM sleep was identified when EEG showed a prominent hippocampal theta rhythm 
and EMG tone was absent except for occasional muscle twitches (see Figure 4.2). 
 
 
 
Figure 4.2. Representative image produced by the visualization software, showing 16 seconds of REM 
sleep. 
 
 
Care was taken to exclude epochs of intermediate sleep (i.e., when EEG displayed 
prominent sleep spindles on a background of  wave activity). With these criteria, REM 
sleep was discriminated from the states of wakefulness and NREM sleep. In fact, during 
wakefulness the EEG displayed a pattern of low-voltage, high-frequency activity and 
nuchal electromyographic tone was present. During NREM sleep, on the other hand, the 
EEG showed high-voltage, low-frequency activity ( waves), with interspersed sleep 
Time (s) 
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spindles and K complexes and EMG tone was present, although lower than that in 
wakefulness (see Figure 4.3).  
 
 
 
Figure 4.3. Representative image produced by the visualization software, showing 10 seconds of NREM 
sleep followed by an awakening. 
 
 
4.5.2 Analysis of phasic hypertensive events 
Data analysis was aimed at characterizing changes in MAP, HP, EEG and EMG 
during phasic hypertensive events in REM sleep. Analysis was performed on episodes 
of REM sleep of duration greater than 30 s.  
Beat-to-beat time series of heart period (HP) and mean arterial pressure (MAP) were 
obtained from the arterial pressure signal.  
HP was determined as the time interval between the onsets of successive systolic 
upstrokes (see Figure 4.4) and accuracy of the determination was ensured by manual 
editing of all the tracings. MAP was computed as the average arterial pressure during 
each HP. The analysis was performed on MAP because MAP is more reliable than 
systolic pressure in long-term pressure recordings in rats (Oosting et al., 1997b).  
Time (s) 
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Figure 4.4. The drawing illustrates the determination of Heart Period (HP) as the time interval between 
the beginnings of successive systolic upstrokes (dots). 
 
 
The bipolar EEG signal was analyzed to compute the frequency of the theta rhythm 
adapting the technique proposed by Sei and Morita (1996) (Sei & Morita, 1996). The 
analysis was performed on consecutive windows of 1 s duration and 0.75 s overlap. On 
each window, the EEG was band-pass filtered (Butterworth 1 pole filter) between 5 and 
10 Hz. The theta frequency was determined as the reciprocal of the mean interval 
between successive points, at which the sign of the band-pass filtered EEG signal 
switched from negative to positive. 
The EMG signal was analyzed to compute its root mean square (rms). The rms, also 
called the quadratic mean, is a statistical measure of the magnitude of a varying 
quantity. The rms is especially useful when the variable analyzed assumes both positive 
and negative values, as is the case for the EMG signal. Similarly to the analysis of the 
EEG, the analysis of the EMG was performed on consecutive windows of 1 s duration 
and 0.75 s overlap. On each window, the EMG values sampled at 128 Hz were squared, 
summed, and divided by their number (i.e., 128). The root mean square of this quantity 
was finally computed to determine the EMG rms in the window.  
Time series of HP, MAP, EEG theta frequency and EMG rms were re-sampled at 16 
Hz by linear interpolation (piecewise cubic Hermite polynomials) to yield data. Thus, 
all the signals were expressed with the same time axis.  
The re-sampled time series of HP and MAP were low-pass filtered at 0.8 Hz (3 pole 
Butterworth filter), to eliminate fluctuations in cardiovascular variables around the 
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breathing rate, which would confound their changes associated with phasic hypertensive 
events.  
Phasic hypertensive events in REM were automatically detected by applying 
quantitative criteria compatible with a definition of the phasic hypertensive events as 
phasic increases of arterial pressure with prominent amplitude. In particular, a phasic 
hypertensive event was defined as a MAP increase of at least 15 mmHg above baseline 
value for more than 1 s. The baseline MAP value was defined as the average MAP 
value in the REM sleep episode under study. 
The variance of low-pass filtered time series of HP and MAP was computed within 
each episode of REM sleep, which comprised at least one phasic hypertensive event. 
For each hypertensive event, the signals were then retained for analysis in the time 
interval starting 10 s before the MAP peak and ending 8 s after it. Such time interval 
had an extension appropriate to evidence all signal changes associated with 
hypertensive events, as assessed during preliminary analyses. 
The signals in each time interval were then normalized to allow their comparison. The 
normalization procedure consisted of subtracting from each signal its mean value in the 
REM sleep episode under study. The EMG rms signal was further divided by its mean 
value in the REM sleep episode to compensate for confounding effects due to variable 
gain settings of the amplifier in different recordings. 
After this normalization procedure, a coherent averaging of the signals during phasic 
hypertensive events was performed within each rat by aligning the data sequences 
temporally with the peak of the MAP surge. (Challis & Kitney, 1990). 
At each time point in the interval comprising the phasic hypertensive events, the 
median values of the signals were computed within rat. Thus, for each rat, the analysis 
yielded four curves, describing the dynamics of HP, MAP, EEG theta frequency and 
EMG rms, respectively, that are associated with phasic hypertensive events. The median 
was chosen instead of the mean because it is more robust to extreme values in the 
signals. 
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4.6 Statistical analysis 
 
Statistical testing was performed using standard procedure (SPSS, 
http://www.spss.com). Independent sample t tests were applied to test the significance 
(P < 0.05) of pre-planned comparisons between SHR and WKY rats and between SHR 
and SHRace. The t-test relies upon the assumption of homogeneity of variance, which 
was tested with the test of Levene. In case of a significant Levene test, which indicates 
the rejection of such assumption, the degrees of freedom used in the t-test were reduced 
to adjust for the increased likelihood of committing a type I error.  
Data were expressed as mean within rat group ± SEM with n = 7 for each group. 
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5. Results 
 
 
5.1 Characteristics of the animals under study 
 
5.1.1 Body Weight of the animals under study 
Table 5.1 shows values of body weight the day of the surgery, when rats were 9 week 
old, and the average weight during the recordings, one week later. Although a small 
weight loss occurred shortly after surgery, it is evident from the data that animals in all 
groups regained weight completely by the time of the recordings. No significant 
differences in body weight occurred either between SHR and WKY rats or between 
SHR and SHRace during the recordings. 
 
 
 WKY SHR SHRace 
Body weight at surgery (g) 235 ± 9 239 ± 6 242 ± 4 
Body weight during the recordings (g) 243 ± 9 244 ± 5 241 ± 5 
 
Table 5.1. Mean values of body weight at surgery and during the recordings. WKY, Wistar Kyoto rats 
(n=7); SHR, Spontaneously Hypertensive Rats (n=7); SHRace, Spontaneously Hypertensive Rats treated 
with Enalapril (n=7). Values are mean ± SEM. 
 
 
5.1.2 Dose of Enalapril maleate received by SHRace rats 
Figure 5.1 shows the estimated daily dose of Enalapril maleate received by rats of the 
SHRace group from the 4th week of age to the end of the recordings. Doses were 
estimated based on the concentration of Enalapril in the water and daily measurements 
of body weight and water consumption. The mean daily dose of Enalapril received was 
26.8 ± 0.2 mg/Kg and was remarkably stable across days and animals.  
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Figure 5.1. Estimated dose of Enalapril maleate received daily by SHRace rats from the 4th week of age 
to the end of the recordings. The green strip highlights the desired dose of the drug (25-30 mg/Kg) 
(Adams et al., 1990). The 35th day of therapy, which is marked with a blue triangle, corresponds to the 
surgery. Post-operative recovery occurred between the 36th and the 40th day, while experimental sessions 
were scheduled between the 41st and the 45th day. 
 
 
5.1.3 Arterial blood analysis  
Table 5.2 shows the results of the arterial blood analysis. The arterial pH was 
significantly lower in SHR than in WKY rats, whereas it was similar and not 
significantly different between SHR and SHRace. No significant differences were 
observed in the concentrations of the partial pressure of oxygen and carbon dioxide, 
sodium ions, potassium ions, calcium ions, glucose, and lactate. Hematocrit was 
significantly lower in SHR than in SHRace.  
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 WKY SHR SHRace 
pH 7.47 ± 0.01* 7.44 ± 0.01 7.44 ± 0.01 
PaCO2 (mmHg) 37 ± 2 39 ± 1 39 ± 1 
PaO2 (mmHg) 90 ± 2 92 ± 3 85 ± 2 
[Na+] (mM) 142 ± 1 142 ± 1 143 ± 1 
[K+] (mM) 3.4 ± 0.1 3.6 ± 0.1 3.7 ± 0.2 
[Ca2+] (mM) 0.63 ± 0.05 0.57 ± 0.05 0.61 ± 0.09 
[glu] (mM) 6.3 ± 0.3 6.3 ± 0.1 6.3 ± 0.1 
[lat] (mM) 0.9 ± 0.1 0.7 ± 0.1 0.7 ± 0.1 
Hct (%) 40 ± 1 41 ± 1 44 ± 1* 
 
Table 5.2. Arterial blood analysis: pH, PaCO2 and PaO2 are arterial partial pressures of carbon dioxide 
and oxygen, respectively; [Na+], [K+], [Ca++], [glu], and [lat] are concentrations of sodium ions, 
potassium ions, calcium ions, glucose, and lactate, respectively; Hct, hematocrit. WKY, Wistar Kyoto rats 
(n=7); SHR, Spontaneously Hypertensive Rats (n=7); SHRace, Spontaneously Hypertensive Rats treated 
with Enalapril (n=7). Values are mean ± SEM. *, P < 0.05 vs. SHR. 
 
 
5.2 Phasic hypertensive events in REM sleep 
 
A total of 1191 phasic hypertensive events were detected during REM sleep in the 
three groups of animals studied. In particular, 471 events were detected in SHR, 433 in 
WKY rats, and 287 in SHRace. 
 
 
5.2.1 Mean values and variance of HP and MAP  
The mean values of HP in episodes of REM sleep with phasic hypertensive events are 
reported in Figure 5.2. HP was significantly lower in SHR than in SHRace, while it did 
not differ significantly between SHR and WKY rats. 
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Figure 5.2. Mean values of heart period in episodes of rapid-eye-movement sleep with phasic 
hypertensive events. WKY, Wistar Kyoto rats (n=7); SHR, Spontaneously Hypertensive Rats (n=7); 
SHRace, Spontaneously Hypertensive Rats treated with Enalapril (n=7). Values are mean ± SEM. *, P < 
0.05 vs. SHR. 
 
 
The mean values of MAP in episodes of REM sleep with phasic hypertensive events 
are reported in Figure 5.3. MAP was significantly higher in SHR than either in WKY 
rats or SHRace. 
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Figure 5.3. Mean values of mean arterial pressure in episodes of rapid-eye-movement sleep with phasic 
hypertensive events. WKY, Wistar Kyoto rats (n=7); SHR, Spontaneously Hypertensive Rats (n=7); 
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SHRace, Spontaneously Hypertensive Rats treated with Enalapril (n=7). Values are mean ± SEM. *, P < 
0.05 vs. SHR.    
 
 
The variances of low-frequency (< 0.8 Hz) fluctuations of HP in the same episodes 
are reported in Figure 5.4. The variance of HP was significantly lower in SHR than in 
SHRace, whereas it did not differ significantly between SHR and WKY rats. 
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Figure 5.4. Variance of low frequency (<0.8 Hz) fluctuations of heart period (HP) in episodes of rapid-
eye-movement sleep with phasic hypertensive events. WKY, Wistar Kyoto rats (n=7); SHR, 
Spontaneously Hypertensive Rats (n=7); SHRace, Spontaneously Hypertensive Rats treated with 
Enalapril (n=7). Values are mean ± SEM. *, P < 0.05 vs. SHR. 
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The variances of low-frequency (< 0.8 Hz) fluctuations of MAP in the same episodes 
are reported in Figure 5.5. The variance of MAP was significantly higher in SHR than 
either in WKY rats or SHRace.  
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Figure 5.5. Variance of low frequency (<0.8 Hz) fluctuations of mean arterial pressure (MAP) in 
episodes of rapid-eye-movement sleep with phasic hypertensive events. WKY, Wistar Kyoto rats (n=7); 
SHR, Spontaneously Hypertensive Rats (n=7); SHRace, Spontaneously Hypertensive Rats treated with 
Enalapril (n=7). Values are mean ± SEM. *, P < 0.05 vs. SHR. 
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5.2.2 Mean values of THF and EMG rms 
The mean values of THF in episodes of REM sleep with phasic hypertensive events 
are reported in Figure 5.6. THF was significantly higher in SHR than in WKY rats, 
while it did not differ significantly between SHR and SHRace. 
The mean values of EMG rms were 3.95	10-2 ± 5.7	10-3, 3.93	10-2 ± 4.9	10-3, and 
4.69	10-2 ± 6.8	10-3 in WKY rats, SHR, and SHRace, respectively. The mean values of 
EMG rms did not differ significantly between SHR and either WKY rats or SHRace. 
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Figure 5.6. Mean values of theta frequency in episodes of rapid-eye-movement sleep with phasic 
hypertensive events. WKY, Wistar Kyoto rats (n=7); SHR, Spontaneously Hypertensive Rats (n=7); 
SHRace, Spontaneously Hypertensive Rats treated with Enalapril (n=7). Values are mean ± SEM. *, P < 
0.05 vs. SHR. 
 
 
5.2.3 Dynamics of HP, MAP, THF and EMG rms associated 
with phasic hypertensive events 
Representative examples of phasic hypertensive events in WKY rats, SHR, and 
SHRace are reported in Figures 5.7, 5.8, and 5.9, respectively. In the three examples 
provided, phasic hypertensive events were associated with tachycardia, which was 
evident from the arterial pressure signal, an acceleration of the theta rhythm and a 
phasic increase in EMG activity. 
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Figure 5.7. Representative example of a phasic hypertensive event during rapid-eye-movement sleep in a 
Wistar Kyoto rat. From the top: arterial pressure (mmHg, red line); bipolar electroencephalogram (black 
line); electromyogram (black line). Time 0 corresponds to the peak of the phasic hypertensive event.  
 
Figure 5.8. Representative example of a phasic hypertensive event during rapid-eye-movement sleep in a 
Spontaneously Hypertensive rat. From the top: arterial pressure (mmHg, red line); bipolar 
electroencephalogram (black line); electromyogram (black line). Time 0 corresponds to the peak of the 
phasic hypertensive event.  
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Figure 5.9. Representative example of a phasic hypertensive event during rapid-eye-movement sleep in a 
Spontaneously Hypertensive rat treated with Enalapril. From the top: arterial pressure (mmHg, red line); 
bipolar electroencephalogram (black line); electromyogram (black line). Time 0 corresponds to the peak 
of the phasic hypertensive event.  
 
 
These associations were highly reproducible, as they were fully confirmed by the 
quantitative analysis performed with coherent averaging (see Methods). The results of 
this analysis are shown in Figures 5.10, 5.11, 5.12 and 5.13.  
The coherent averaging procedure revealed that HP decreased for the whole duration of 
the phasic hypertensive events (Figure 5.10). The inspection of the curves described by 
the signals during phasic hypertensive events revealed in all groups a negative peak of 
the HP signal (Figure 5.10) and positive peaks of THF (Figure 5.12) and EMG rms 
signals (Figure 5.13), all peaks occurring from 4 s before the MAP peak to 2 s after it 
(Figure 5.11).  
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Figure 5.10. Result of the coherent averaging performed on heart period during phasic hypertensive 
events in rapid-eye-movement sleep. Data are mean ± SEM in Wistar Kyoto rats (blue, n = 7), 
Spontaneously Hypertensive Rats (red, n = 7), and Spontaneously Hypertensive Rats treated with 
Enalapril (black, n = 7). Delta HP, difference between heart period and its baseline value. Time 0 
corresponds to the peak of the phasic hypertensive event. 
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Figure 5.11. Result of the coherent averaging performed on mean arterial pressure during phasic 
hypertensive events in rapid-eye-movement sleep. Data are mean ± SEM in Wistar Kyoto rats (blue, n = 
7), Spontaneously Hypertensive Rats (red, n = 7), and Spontaneously Hypertensive Rats treated with 
Enalapril (black, n = 7). Delta MAP, difference between mean arterial pressure and its baseline value. 
Time 0 corresponds to the peak of the phasic hypertensive event. 
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Figure 5.12. Result of the coherent averaging performed on the frequency of the electroencephalographic 
theta rhythm during phasic hypertensive events in rapid-eye-movement sleep. Data are mean ± SEM in 
Wistar Kyoto rats (blue, n = 7), Spontaneously Hypertensive Rats (red, n = 7), and Spontaneously 
Hypertensive Rats treated with Enalapril (black, n = 7). Delta THF, difference in the frequency of the 
theta rhythm and its baseline value. Time 0 corresponds to the peak of the phasic hypertensive event. 
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Figure 5.13. Result of the coherent averaging performed on the electromyographic activity during phasic 
hypertensive events in rapid-eye-movement sleep. Data are mean ± SEM in Wistar Kyoto rats (blue, n = 
7), Spontaneously Hypertensive Rats (red, n = 7), and Spontaneously Hypertensive Rats treated with 
Enalapril (black, n = 7). Delta EMG rms, difference between the root mean square of electromyographic 
activity and its baseline value. Time 0 corresponds to the peak of the phasic hypertensive event. 
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Thus, for each rat, subsequent analysis was focused on: a) the positive peak value of 
MAP; b) the negative peak value of HP; c) the positive peak value of THF; and d) the 
positive peak value of the EMG rms. 
The values of MAP at the peak of the phasic hypertensive events were 24.17 ± 0.58, 
24.63 ± 0.69, 23.28 ± 0.57 in WKY rats, SHR and SHRace, respectively. The values of 
MAP at the peak did not differ significantly between SHR and either WKY rats or 
SHRace.  
The magnitude of the negative peak value of HP was significantly lower in SHR than 
either in WKY rats or SHRace (Figure 5.14).  
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Figure 5.14. Mean values of heart period at the negative peak of phasic hypertensive events. WKY, 
Wistar Kyoto rats (n=7); SHR, Spontaneously Hypertensive Rats (n=7); SHRace, Spontaneously 
Hypertensive Rats treated with Enalapril (n=7). Values are mean ± SEM. *, P < 0.05 vs. SHR. 
 
 
The time shift between the negative peak of HP and the MAP peak is reported in 
Table 5.3 and did not differ significantly between rat strains. 
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 WKY SHR SHRace 
Time at min HP (s) -0.42 ± 0.07 -0.25 ± 0.31 -0.82 ± 0.13 
Time at max THF (s) -1.34 ± 0.11 -1.27 ± 0.11 -1.46 ± 0.08 
Time at max EMG rms (s) -1.46 ± 0.08 -1.36 ± 0.13 -1.20 ± 0.29 
 
Table 5.3. Time shifts between the peak of mean arterial pressure and the negative peak of heart period 
(min HP), the positive peak of theta frequency (max THF), and the positive peak of electromyographic 
activity (max EMG rms). WKY, Wistar Kyoto rats (n=7); SHR, Spontaneously Hypertensive Rats (n=7); 
SHRace, Spontaneously Hypertensive Rats treated with Enalapril (n=7). Values are mean ± SEM.  
 
 
The positive peak value of THF was significantly lower in SHR than either in WKY rats 
or SHRace (Figure 5.15). The time shift between the THF peak and the MAP peak is 
reported in Table 5.3 and did not differ significantly between rat strains. 
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Figure 5.15. Mean values of theta frequency (THF) at the peak of phasic hypertensive events. WKY, 
Wistar Kyoto rats (n=7); SHR, Spontaneously Hypertensive Rats (n=7); SHRace, Spontaneously 
Hypertensive Rats treated with Enalapril (n=7). Values are mean ± SEM. *, P < 0.05 vs. SHR. 
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The values of EMG rms at the peak of the phasic hypertensive events were 0.16 ± 
0.03, 0.10 ± 0.02, 0.13 ± 0.03 in WKY rats, SHR and SHRace, respectively. The values 
of EMG rms at the peak did not differ significantly between SHR and either WKY rats 
or SHRace.  
Similarly, no significant differences were observed between groups in the time shift 
between the peak of EMG rms and the MAP peak Table 5.3. 
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6. Discussion 
 
 
The aim of this study was to investigate whether SHR, which represent the most 
widely used model of essential hypertension, show an altered central autonomic control 
during phasic hypertensive events in REM sleep. The results of the present study 
indicate that the contribution of central autonomic commands to cardiovascular 
variability is reduced in SHR during REM sleep. 
 
 
6.1 Spontaneously Hypertensive Rats 
 
Experiments were performed on male SHR at the 10th week of age. The SHR strain is 
the most used animal model for research on polygenic hypertension and allows full 
control of genetic and environmental confounding factors. SHR were developed by 
Okamoto and colleagues in the early 1960 (Okamoto & Aoki, 1963) as a substrain of 
the WKY genetically-normotensive strain.   
SHR spontaneously develop hypertension without the need of any dietary or surgical 
manipulation (Okamoto & Aoki, 1963). Hypertension develops typically by the third 
week and is maintained throughout adulthood in 100% of the population (Yamori et al., 
1974). In particular, blood pressure of WKY rats reaches adult levels by the 10th week 
of age, but in SHR it continues to rise at least until the age of 20 weeks (Zicha & Kunes, 
1999) (Figure 3.4). SHR develop hypertensive complications similar to those in human 
patients, such as cerebral infarction or hemorrhage, myocardial infarction and 
nephrosclerosis (Yamori et al., 1974). The average life span of SHR is approximately 
18 months. In comparison, Wistar Kyoto rats typically live for at least 30–36 months. In 
the present study SHR at 10 weeks of age were considered, when full-blown 
hypertension is present, while confounding effects due to the long-term organ damage 
associated with the disease were avoided. 
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6.2 Experimental control groups  
 
The SHR strain was developed by selective breeding of WKY animals that presented 
hypertension due to spontaneous random mutation(s) (Okamoto & Aoki, 1963). Thus, 
hypertension was the only phenotype used to control the breeding protocols, making it 
possible that other gene mutations were also captured by this breeding process. To 
summarize, SHR and WKY rats allow the reduction of genetic confounding factors 
within group, because both strains are fully inbred. However, genetic confounders 
possibly unrelated to arterial hypertension do exist between SHR and WKY rats (Carley 
et al., 2000). 
For the reasons mentioned above, the results obtained in SHR with those in two 
control groups were compared. One group consisted of 7 WKY rats, with age and sex 
matched to those of SHR. The other group (SHRace) consisted of 7 SHR, in which 
hypertension was prevented by continuous treatment with Enalapril maleate since the 
fourth week of age, as proposed by Adams et al. (1990). Enalapril is an inhibitor of the 
angiotensin converting enzyme (ACE). Angiotensin II plays a key role in the 
pathogenesis of hypertension in SHR, even though SHR have normal plasma renin 
activity (Bolterman et al., 2005).  
The treatment was well-tolerated by the rats, as shown by their normal body weight 
during the recordings and by the results of the blood gas analysis. During the course of 
the treatment, by adjusting the concentration of Enalapril in drinking water to the daily 
changes in body weight and water intake of the rats, a stable dose of Enalapril of 25-30 
mg/Kg was administered daily (Figure 5.1). This dose was effective in preventing 
hypertension in the SHRace group.  
To summarize, I compared SHR with WKY rats and SHRace. SHR are genetically and 
phenotypically hypertensive. WKY rats are genetically and phenotypically 
normotensive. SHRace are genetically hypertensive but phenotypically normotensive. 
Owing to this experimental design, I could attempt to dissect the contributions of 
hypertension and genetic determinants to the aspect of the cardiovascular phenotype 
under study, i.e., central autonomic control of the cardiovascular system. 
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6.3 Temporal pattern of the changes in cardiovascular 
variables during the phasic hypertensive events 
 
There is ample experimental evidence that central autonomic commands underlie the 
phasic hypertensive events in REM sleep. Phasic hypertensive events occur in REM 
sleep in experimental animals: cat (Mancia et al., 1971); rat (Sei et al., 1999); mouse 
(Campen et al., 2002); lamb (Fewell, 1993; Silvani et al., 2005); and human subjects as 
well (Coccagna et al., 1971). The pressure surges are driven by increases in peripheral 
vascular resistance (Fewell, 1993), particularly in the vascular bed of skeletal muscles 
(Mancia et al., 1971). Such increase in muscle vascular resistance is due to central 
autonomic commands, as shown by its disappearance following sympathectomy but not 
following limb deafferentation (Baccelli et al., 1974).  
In all groups analyzed, the variables under study showed a remarkable variability in 
their pattern among different phasic hypertensive events. This remarkable variability of 
the vegetative phenomena is a well-known feature of REM sleep (Parmeggiani, 1980). 
However, owing to a quantitative analysis (coherent averaging) and to the high number 
of phasic hypertensive events analyzed, I could demonstrate that the variability conceals 
specific patterns of changes in different variables associated with phasic hypertensive 
events. In all groups, coherent averaging revealed a negative peak of the HP signal 
(Figure 5.10) and positive peaks of THF (Figure 5.12) and EMG rms signals (Figure 
5.13), all peaks occurring from 4 s before the MAP peak to 2 s after it (Figure 5.11).  
The coherent averaging procedure revealed that HP decreased for the whole duration 
of the phasic hypertensive events (Figure 5.10), this pattern being clearly evident in all 
groups studied. This finding agrees with previous results obtained in normotensive 
outbred rats of the Sprague-Dawley strain (Zoccoli et al., 2001; Silvani et al., 2003), 
indicating central autonomic commands prevail on the baroreflex at the cardiac level 
during the MAP surges in REM sleep. In fact, the baroreflex would be expected to 
cause bradycardia in response to the increase in MAP, a pattern opposite to the one 
observed. The coupling between hypertension and tachycardia is similar to the pattern 
observed during wakefulness in the course of physical exercise and defense reaction. In 
these conditions, central autonomic commands prevail temporally over negative 
feedback controls such as the baroreflex.  
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In rats, the only previous study on MAP surges reported that heart rate increased 
modestly and non significantly during the MAP surges, while it increased significantly 
after them (Sei & Morita, 1996). Methodological differences between the work of Sei 
and co-workers and my own work may partly underlie the differences in the reported 
results. Indeed, Sei chose bursts of rapid eye movements to synchronize cardiovascular 
variables in the coherent averaging procedure, with a resolution of only 1 s, whereas in 
the present work, data were synchronized at the peak of the MAP surge with a much 
higher resolution. In fact, data were recorded beat-to-beat and subsequently resampled 
at a rate of 16 Hz.  
The prevalence of central autonomic commands at the cardiac level during the MAP 
surges, which is observed in rats, may be species-specific. In newborn lambs (Silvani et 
al., 2005), heart period showed a biphasic fluctuation during MAP surges in REM 
sleep: HP decreased concomitantly with the onset of the phasic increases in MAP, 
whereas it increased over baseline later in the course of the surges. Thus, central 
autonomic commands prevail over the baroreflex on the heart as well as on blood 
vessels at surge onset both in newborn lambs and in adult rats. However, in lambs, but 
not in rats, the baroreflex effect on the heart prevails late in the course of the surges, in 
spite of enduring central control on blood vessel. This different pattern of cardiac 
response to arterial pressure surges may be due to differences between species or to 
differences in developmental age.  
As mentioned above, the coherent averaging procedure evidenced distinct associations 
between the MAP surge and changes in THF and EMG rms. The association of 
cardiovascular, EEG, and EMG phenomena during phasic hypertensive events in REM 
sleep has been previously reported on a quantitative basis by Sei et al. (Sei & Morita, 
1996). The results of the present study are in excellent agreement with their data in 
terms of the magnitude of the increase in THF preceding the MAP surge. In addition, 
the present study evidences quantitatively an association of the MAP surges with an 
increase in the EMG rms, reflecting muscle twitches on a background of muscle atonia. 
Taken together, these results fully support the view that phasic hypertensive events in 
REM sleep are produced by central autonomic commands. These commands manifest at 
the EEG level with an increase in theta frequency, at the muscle level with brief muscle 
twitches, at the cardiac level with tachycardia, and at the circulatory level with arterial 
hypertension.  
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6.4 Peak changes of cardiovascular, EEG, and EMG 
variables during the phasic hypertensive events 
 
The value of MAP at the peak of the phasic hypertensive events was similar between 
groups and did not differ significantly between SHR and either WKY rats or SHRace 
(see Results). This is an interesting observation, because it is apparently in disagreement 
with the notion that vascular reactivity to central autonomic control is enhanced in SHR. 
This notion was introduced by means of an elegant experimental work by Kuo et al. 
(Kuo & Yang, 2000). These authors performed a broad-band electrical stimulation of 
the rostral ventrolateral medulla in anesthetized SHR and recorded the changes in 
arterial pressure that were produced as a result of the stimulation. The evoked variability 
of arterial pressure and the magnitude of the transfer function between the spike rate 
variability of the stimulus and the arterial pressure variability were higher in SHR than 
in WKY rats, these differences being abolished by combined α and β adrenoreceptor 
blockade. The increased reactivity of the cardiovascular system to sympathetic 
commands may underlie the increased variance of arterial pressure observed in SHR 
with respect to WKY rats (Figure 5.5). Given the increased reactivity of arterial 
pressure to rostral ventrolateral medulla in SHR, the peak MAP increase during the 
phasic hypertensive events would be expected to be higher in SHR than in WKY rats. 
However, this difference was actually negligible and not statistically significant. Thus, 
the analysis of the peak MAP value suggests that central autonomic control of 
peripheral resistance is reduced in SHR with respect to WKY rats, this reduction being 
compensated by a greater vascular reactivity. Similarly, the difference in the peak MAP 
value was modest and not statistically significant also between SHR and SHRace, 
although the MAP variance during the whole REM sleep episodes was significantly and 
substantially higher in SHR than in SHRace.  
The hypothesis that in REM sleep, SHR show a reduction in the central autonomic 
control of the cardiovascular system is further supported by the analysis of the increase 
in THF. The positive peak value of THF was significantly lower in SHR than either in 
WKY rats or SHRace (Figure 5.15). The time shift between the THF peak and the MAP 
peak is reported in Table 5.3 and did not differ significantly between rat strains. The 
increase in THF is a more direct correlate of central autonomic commands in REMS 
   82 
than the cardiovascular changes, because its magnitude does not depend on the 
reactivity of the cardiovascular effectors.  
It must be noted that the peak increase in EMG rms did not significantly differ 
between SHR and either WKY rats or SHRace, although it tended to be lower in SHR. 
The control of muscle activity during REM sleep is complex, with bursts of activation 
and inhibition impinging on motorneurons (Chase & Morales, 2005), possibly 
explaining the disagreement between the data on THF and on EMG rms. 
Finally, the analysis of changes in HP associated with phasic hypertensive events fully 
supports the hypothesis that central autonomic control of the cardiovascular system is 
reduced in SHR during REM sleep. The magnitude of the negative peak value of HP 
was significantly lower in SHR than either in WKY rats or SHRace. The time shift 
between the negative peak of HP and the MAP peak is reported in Table 5.3 and did not 
differ significantly between rat strains. As discussed above, a tachycardia in the 
presence of an increase in MAP cannot be ascribed to the baroreflex, but rather reflects 
central autonomic commands.  
To summarize, the present study indicates that the peak MAP increase during the phasic 
hypertensive events in REM sleep did not differ significantly between SHR and WKY 
rats, while on the other hand SHR showed a reduced increase in THF and a reduced 
decrease in HP with respect to WKY rats. The same pattern of changes in MAP, HP, 
and THF was observed between SHR and SHRace. This is an important observation, 
because SHR do not differ from WKY rats only in terms of arterial hypertension, but 
also due to multiple unknown genetic differences. SHR were developed by selective 
breeding of WKY rats based only on the level of arterial pressure. However, in this 
process, multiple genes possibly unrelated to hypertension may have been selected 
together with the genetic determinants of hypertension. The fact that this represents 
more than a theoretical possibility has been convincingly demonstrated by Carley et al. 
(Carley et al., 2000). These authors showed persistent sleep-related breathing disorders 
in SHR despite effective cardiovascular normalization due to long-term captopril 
treatment. Similarly, this study indicated that SHR differ from WKY rats, but not from 
SHRace, in terms of arterial pH and THF. The arterial pH is more acidic in SHR than in 
WKY rats despite similar levels of arterial pCO2 (Table 5.2). This difference may be 
due to a reduced renal tubular reuptake of bicarbonate ions in SHR (Lucas et al., 1988). 
Since no difference was observed between SHR and SHRace, this feature may be due to 
genetic determinants unrelated to hypertension. For what concerns THF, it is interesting 
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to note that lines of rats that differ in their voluntary alcohol drinking behaviour differ 
also in terms of the peak frequency of hippocampal theta activity during REM sleep 
(Morzorati et al., 1994). This suggests that the THF is strongly under genetic control in 
rats. In sharp contrast, the persistence of differences in the peak HP decrease and the 
peak THF increase during MAP surges between SHR and SHRace demonstrates that the 
observed reduction in central autonomic control of the cardiovascular system in SHR is 
not an irreversible consequence of inherited genetic determinants in SHR. Rather, the 
comparison between SHR and SHRace indicates that the observed differences in central 
autonomic control are the result of the hypertension per se. 
 
The present results support the hypothesis that surges, during REM sleep, may 
constitute a diagnostic stress test capable of disclosing pathological differences in 
cardiovascular regulation (Verrier et al., 1996). This distinctiveness of REM sleep may 
be due to the fact that this state represents a stable behavioral condition, devoid of any 
external, voluntary or motivational influence. It must be noted that behavioral trait 
differences between SHR and WKY rats contribute to the increased cardiovascular 
responsiveness to environmental stress in SHR (Knardahl & Hendley, 1990). One 
phenomenon that is unique to REM sleep is the total loss of activity in the antigravitary 
musculature (Jouvet, 1967) and accordingly the stability in terms of metabolic demands. 
On the other hand, in spite of such stability, REM sleep involves prominent fluctuations 
of physiological variables without any evident adaptive function, but determined only 
by the sleep process.  
In conclusion, I analyzed the cardiovascular, EEG, and EMG changes associated with 
phasic hypertensive events during REM sleep in the SHR model of essential 
hypertension. SHR were compared not only with their genetic WKY control strain, but 
also with a group of SHR made phenotypically normotensive by means of a chronic 
treatment with an ACE inhibitor. The results of this study indicate that central 
autonomic control of the cardiovascular system is reduced in SHR during REM sleep, 
and provide evidence that this reduction is due to hypertension per se rather than to 
genetic factors. This work supports the view that the study of cardiovascular regulation 
in sleep provides fundamental insight on the pathophysiology of hypertension. Systemic 
hypertension is associated with sleep-related autonomic dysregulation (Kuo et al., 
2004a) and breathing disorders (Carley et al., 2000) as well as with alterations in the 
sleep pattern (Kuo et al., 2004b). The study of the interaction between sleep and 
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hypertension may thus contribute to the understanding of this disease, which is a major 
health problem in European countries (Wolf-Maier et al., 2003) with its burden of 
cardiac, vascular, and renal complications.  
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